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Haematopoietic stem cells (HSCs) are present in the bone 
marrow (BM) and maintain our blood system throughout life. 
These cells have clinical importance and their transplantation 
constitutes the most common type of stem cell therapy 
available. Lack of BM donors and our inability to expand HSCs 
ex vivo; make it desirable to be able to generate patient 
specific HSCs from pluripotent stem cells. Using the zebrafish 
as model organism we have two parallel long-term projects, 
one to address the cellular origin of HSCs and the other to 
understand an aspect of the molecular programming of HSCs. 
Establishing a CreERT2 system we have labelled cells by 
inducing with 4-OHT at different time points during embryonic 
development.  Since lineage tracing experiment are long term 
experiments, only a part of this was done. During this project, 
however methods to isolate, section and stain the adult 
zebrafish kidney, which is the site of adult haematopoiesis in 
the fish, have been established which would later be used to 
look at the kidneys of the fish that have been recombined in 
order to trace the origin of the cells that seed the kidney. 
 The Cre/loxP system is used to force expression of a 
dominant negative AKT and a constitutively active AKT in 
endothelial cells. Characterisation of these lines was carried 
out in order to see whether these lines could be used in the 
future to study the effect of the loss and gain of function of the 
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Chapter I: General Introduction 
1.1. Haematopoiesis 
Haematopoiesis is the process by which mature cells of all 
blood lineages are formed in an organism. This process is 
sustained throughout life by haematopoietic stem cells (HSCs) 
(Weissman et al., 2000). HSCs are immature, multipotent (can 
give rise to cells of all blood lineages) progenitors that are 
capable of self-renewal. These cells reside in the bone marrow 
(BM) of adult mammals.  
1.2. Clinical importance of HSCs 
In a healthy human adult an average of 1010-1011 new blood 
cells are produced everyday to maintain homeostasis. HSCs 
are extremely potent and in case of an injury and thereby 
complete loss of both peripheral blood and bone marrow cells, 
it takes only a few HSCs to revive the blood system back to 
normal Bordignon (2006). This is what makes HSCs of 
enormous clinical relevance today.  
HSCs are being widely used in bone marrow (BM) transplants 
to re-establish the loss of the blood system in patients with BM 
failure or due to the therapy administered to treat leukemia or 
a solid cancer.  Therapies usually involve autologous (using 
the patientÕs own BM) bone marrow transplants and allogeneic 
(BM taken from an antigen-matched donor, usually a parent or 
sibling). Autologous bone marrow transplants are used 
depending on whether functional, disease-free HSCs can be 
procured from the patient. Autologous BM transplants are 
preferred to allogenic transplants, because the latter bares the 
risk of causing graft versus host disease or graft rejection. The 
lack of BM donors and our inability to expand HSCs ex vivo 
require generation of patient specific HSCs from pluripotent 
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stem cells (Murry and Keller, 2008). 
1.3. Haematopoiesis occurs in waves in the mammalian 
conceptus 
In the vertebrate conceptus haematopoiesis occurs in 2 
successive waves: 
A primitive wave in which primitive red blood cells and myeloid 
cells are formed, and a permanent or definitive wave, which 
occurs later in development to form mature cells of erythroid, 
myeloid and lymphoid lineages (T and B cells). HSCs are 
formed during this second or definitive wave (Medvinsky et al., 
2011). 
1.3.1. Primitive haematopoiesis in the mouse!
In the 1970s in a sophisticated study, using chimeric 
experiments in which quail embryos were transplanted into the 
yolk sac of a chick showed that cells coming from the yolk sac 
did not make a significant contribution to adult 
haematopoiesis. This would mean that HSCs found in the adult 
came from the embryo itself (Dieterlenlievre, 1975; Medvinsky 
et al., 2011). The relevance of the data generated in the avian 
system to all vertebrates became clear only when these 
findings were confirmed in the murine system. 
In mammals and birds the primitive wave takes place in the 
mesodermal layer of the extraembryonic yolk sac (YS).  
In the mouse YS, at around embryonic day 7.5 (E7.5) blood 
cells emerge from a population of cells known as 
haemangioblasts. These cells leave the posterior primitive 
streak to undergo haematopoietic differentiation in which they 
differentiate to form blood and endothelial cells. This 
differentiation takes place in the YS (Huber et al., 2004). 
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Colony forming units CFU-C are described as progenitor cells 
that form haematopoietic cell colonies on solid media when 
supplied with the right nutrients and cytokines. These cells do 
not have the potential to self-renew, although some may be 
able to form colonies when re-plated (Medvinsky et al., 2011). 
It has been seen that cells isolated from the YS are myeloid 
progenitors that are capable of forming CFU-Cs. 
Another term, colony forming unit-splenic (CFU-S) is used for 
cells that are undifferentiated, immature progenitor cells 
capable of forming colonies in spleens of irradiated mice. CFU-
S is the term used to describe adult type or definitive 
haematopoietic stem cells (dHSC) (Medvinsky et al., 2011).  
1.3.2. Definitive haematopoiesis in the mouse 
It has been seen that the aorta of the E10.5 murine embryo 
displays HSC clusters and these clusters were responsible for 
establishing definitive haematopoiesis (Adamo and Garca-
Cardea, 2012) 
Definitive haematopoiesis occurs from E11.5 in the aorta-
gonad-mesonephros (AGM) of the murine embryo and this 
region has been shown to be the hub of HSC formation. At the 
pre-liver stage of murine development the 11.5E embryo 
contains at least a single HSC in the AGM, placenta and yolk 
sac and hence subsequent HSCs are generated.  
The fetal liver begins to get colonised by HSCs by E12.5. 
Simultaneously HSCs are seen to be in circulation. HSCs 
further multiply in the fetal liver and this multiplication is 
mediated by Sox17 a transcription factor and molecules such 
as angiopoietin-like factors. β1 integrins also play a pivotal 




HSCs in the developing embryo do not have a marker specific 
to them. Cells migrate from the dorsolateral plate (DLP) to the 
midline to form the dorsal aorta. DLP derived cells form 
endothelial cells that express flk1 and fli1. Hematopoietic cells 
are marked by Scl, Gata2 and lmo2. 
 Once the cells of the DLP reach the midline, it has be seen 
that some of these cells express crucial haematopoietic 
transcription factors such as Runx1 (Runt-related transcription 
factor 1) that has been shown to be crucial in the formation of 
haematopoietic clusters. Runx1 is expressed in the HSCs that 
are in the AGM. 
In the murine conceptus the bone morphogenetic protein4 
(Bmp4) and the sonic hedgehog (shh) have been found to be 






In Dr. Martin GeringÕs lab we are studying haematopoiesis 
during vertebrate embryogenesis using the zebrafish (Danio 
rerio) as a model organism. 
1.4. Zebrafish as a model organism to study vertebrate 
haematopoiesis 
¥ The transparent nature of its embryo makes the 
zebrafish extremely favourable for in vivo imaging thus 
making them an ideal model to study haematopoiesis. 
¥ Especially for HSC development, zebrafish have a 
circulatory system similar to that of humans, thus 
making it a good model to understand and study 
haematopoiesis. 
¥ Zebrafish can easily be genetically modified hence 
making it easy to carry out transgenic studies. 
 
1.4.1. Haematopoiesis in zebrafish  
Like with all other vertebrates haematopoiesis in zebrafish 
occurs in 2 successive waves; 
A primitive wave and a secondary or definitive wave. 
 
1.4.1.1. Primitive haematopoiesis in zebrafish 
In the zebrafish this wave takes place in the intermediate cell 
mass (ICM) (Davidson and Zon, 0000). The ICM is a chord of 
cells located in the trunk midline between the notochord, the 
endoderm and the somites. These cells then differentiate into 
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primitive red blood cells and the ICM further differentiates to 
form the two major trunk vessels, the dorsal aorta (DA) and 
the posterior cardinal vein (PCV) 
Erythroid progenitors express the gata1 transcription factor 
and definitive erythropoiesis is dependent on gata1(Ellett and 
Lieschke, 2010). Myeloid progenitors however express spi1 
(also known as pu.1). Both gata1 and spi1 seem to interact 
with each other (Rhodes et al., 2005) but play no significant 
role in the next wave of haematopoiesis which is the definitive 
wave.  
Dividing haematopoiesis into waves is not straightforward, 
because the waves could be distinguished on the basis of a 
number of factors such as the time or region in which they 
occur. 
Another wave is said to occur in the caudal haematopoietic 
tissue (CHT) of the developing embryo just before the 
definitive wave is believed to begin. This wave occurs from 26-
48 hpf, is not dependent on notch and forms erthythromyloid 
progenitors (EMPs) from lmo2+ precursors (Bertrand et al., 
2010). Recent lineage tracing experiments by Warga et al 
(2009) suggest that EMP formation takes place at the start of 
gastrulation at around 5hpf, differentiating these cells from 
unipotent progenitors that seed the rostral blood island (RBI) 
and the RBCs that are formed during primitive haematopoiesis 
(Warga et al., 2009). 
1.4.1.2. Definitive haematopoiesis in zebrafish 
In the zebrafish the definitive wave begins at about 23-24hpf. 
At this time HSCs begin to emerge from the ventral aspect of 
the dorsal aorta (vDA), also referred to as the hemogenic 
endothelium. The vDA in the zebrafish is analogous of the AGM 
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region in the mouse. The HSCs begin to appear with the 
advent of circulation, when the first primitive blood cells enter 
circulation at around 24hpf.  
HSCs are identified by the expression of the transcription 
factors runx1 and c-myb, and by their intimate association to 
the vDA (Gering and Patient, 2005). In runx1 morphants there 
is a loss of c-myb expressing definitive progenitors as well as a 
loss of T-cells in the thymus (Gering and Patient, 2005; Kalev-
Zylinska et al., 2002). T-cells are progeny of HSCs in the 
vertebrate conceptus and the loss of T-cells in the runx1 
morpholino experiments suggests that the runx1 positive cells 
in the ICM are HSCs or their precursors. 
Cells leave the vDA in a process called Ôendothelial to 
haematopoietic transitionÕ (ETH) where elongated endothelial 
cells leave the vDA to assume a more rounded morphology 
before leaving the lumen. During ETH, which is optimum at 
30-60 hpf, endothelial cells transition to become blood cells. 
This process is runx1 dependent and in embryos lacking runx1 
it has been seen that when cell a tries to exit does not survive 
(Kissa and Herbomel, 2010). 
Studies carried out on zebrafish mutants such as the 
mindbomb, smoothened (smo) and embryos treated with a 
VEGF (vascular endothelial growth factor) receptor inhibitor 
showed that notch, hedgehog and vegf are required for 
definitive haematopoiesis, but not for primitive erythropoiesis 




Chapter 2: Materials and Methods 
2.1. Zebrafish husbandry 
All zebrafish lines, both adult and embryos were raised, bred 
and maintained according to guidelines in The Zebrafish Book 
(Westerfield, 2000). 
2.1.1. Lines that were used and generated for the 
flk1Cre/flk1CreERT2 experiments!
A number of lines were used in our experiments and were as 
follows; F0 generation fish, these are the injected fish and 
they were SN9 Tg(flk1CreERT2) HA.M date of birth (DOB) of 
these was 28.4.11 was the founder of qmc104. F1 generation 
fish which were SN51 Tg(flk1CreERT2;Cre reporter) DOB of 
these fish was 27.7.11 and are the qmc104s. Other lines used 
were SN41 Tg(ef1α-loxP-GFP-terminator-loxP-dsRed) are 
heterozygous carriers for the transgene and the DOB for these 
fish is 12.7.11. These fish will be referred to as Cre reporter.  
SN903 (flk1Cre) (founder of qmc101) carries the transgene 
(flk1CreXERT2) and ÔXÕ referes to a frameshift between the Cre 
and the ERT2, making the Cre in this line constitutively active 
and will be referred to as flk1Cre throughout the text. The 
SN55 (flk1Cre) are the F1 generation of the qmc101 and their 
DOB is 12.9.11 these fish will be referred to as qmc101. 
SN907 (qmc101; Cre reporter) and the DOB for these dish is 
30.9.10. Wild type (wt) fish used were the SN19 and SN26. 
2.1.2. Lines used and generated for the PI3K/AKT study!
F0 fish SN44 Tg(ef1α-loxP-Cerulean-loxP-HA-AKT1K179M) 
DOB of these was 20.7.11 and these fish will be referred to as 
KDAKT for convenience.  
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SN47 Tg(ef1α-cerulean-terminator-myrAKT) the DOB of this 
stock is 22.7.11 and these fish will be referred to as myrAKT. 
 
F1 Fish SN69 Tg(ef1α-cerulean-terminator-myrAKT)qmc162 DOB 
8.11.11.  




SN56 wild type (wt) DOB 7.10.11 
 
All fish and their embryos were maintained at 28.5¡C. All work 
carried out on zebrafish including culling were according to the 
standard Home office regulations. 
2.2. Isolation of genomic DNA (gDNA) from embryos 
Genomic DNA was to be isolated from embryos that were first 
dechorionated. The number of embryos used to extract DNA 
from fish is depicted in Table1 Chapter 4. 
We then treated the embryos with extraction buffer which was 
to be added in a volume ten times the number of embryos 
present in the eppendorf tube. The tubes were left overnight 
at 55¡C.  
2.3. Phenol/chloroform extraction 
In order to remove any remaining proteins and other 
impurities from the tubes it is important to carry out 
phenol/chloroform extraction. Around 650µl of phenol: 
chloroform:isoamyl (25:24:1) alcohol was added The tubes 
were first centrifuged at 13000rpm for 5minutes. After 
spinning there were two layers formed, an aqueous layer and 
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a yellow phenol layer. The aqueous layer was transferred to a 
new set of tubes and the phenol layer discarded. This step was 
done under a fume hood. In order to get rid of any traces of 
phenol in the aqueous layer it was treated with equal volumes 
of a 24:1 chloroform:isoamyl alcohol solution. Each tube was 
vortexed for 1 minute before centrifuging them at 13000rpm 
for 5 minutes. Two layers were obtained an aqueous layer (top 
layer) and chloroform: isoamyl layer. The aqueous layer was 
transferred to a new set of tubes. To the aqueous layer 1/10th 
the volume of 3M pH5.2 potassium acetate was added 
followed by 2.5 volumes of 100% ethanol in order to 
precipitate out the DNA. Tubes were then centrifuged at 
13000rpm/15min. The supernatant was discarded, making 
sure not to disturb the pellet. The pellet was washed with 70% 
ethanol to remove any salts and centrifuged if required. The 
tubes were inverted to get rid of the alcohol and left inverted 
to dry completely as any remnants of ethanol would interfere 
with the enzyme Taq polymerase in the PCR. Once the pellet 
was completely dry, it was reconstituted in tris EDTA (TE) 
buffer. TE contains EDTA that is a chelating agent and 
prevents nucleases from degrading DNA. 
The centrifuge used was a ÔFisher Scientific accuspin MicroÕ 
and the vortex used was ÔGrant bio pv-1Õ. 
2.4. Polymerase chain reaction (PCR)  
In order to carry out a PCR, depending on the number of 
samples a master mix was prepared. We prepared a master 
mix for 15 samples, which was a total of 22.5µl. The master 
mix included 37.5µl of 10X buffer, 262.5µl of sterile distilled 
water, 7.5µlof 10mM dNTPs and 15µl of each primer #143 
(Forward Primer) 5Õ-CTGAATAAGTAGATAGCCTATC-3Õ which 
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anneals in the flk1 promoter fragment and Primer #144 
(Reverse Primer) 5Õ-CTCATCACTCGTTGCATCG-3Õ which 
anneals in the Cre. Both the primers were in a concentration of 
10pmol/µl; 10uM. Once the master mix was ready in PCR 
tubes, to 22.5µl of master mix 2µl of DNA template and 0.5µl 
of Taq polymerase was added. The total volume in each PCR 
tube was 25µl. Once all the tubes were ready they were placed 
in the PCR machine ÔTechne TC-512Õ and the PCR conditions 
were set to 1cycle at 90¡C for 2minutes, 40 cycles of 
denaturation at 94¡C for 20 seconds, annealing at 56¡C for 30 
seconds, and extension at 72¡C for 50 seconds, 1cycle at 72¡C 
for 5 minutes was done to check all the DNA has been 
replicated and finally 1cycle at 4¡C was on hold indefinitely. 
2.5. Agarose gel electrophoresis 
The PCR products were separated on a 1.5% agarose gel 
prepared in 0.5X TAE buffer to which 4µl of ethidium bromide 
was added. 10µl of the samples was mixed with 2µl of loading 
dye. The gel was run in a Gel Exel Ultra V2 electrophoresis 
chamber at 100v for 30 minutes.  
 
2.6. In vivo fluorescent imaging 
Fluorescence analysis in embryos was done on a Nikon 
SMZ1500 microscope fitted with filters to detect fluorescence. 
These microscopes were either attached to a Nikon DXM1200F 
or Nikon Digital Sight DS-U1 that took coloured images. A 
more sensitive camera was the Hamamatsu ORCA-ER C4742-
80 digital camera. Although extremely sensitive it took only 
black and white images that could be pseudocoloured. The 
Hamamatsu was used with the Nikon Eclipse 80i microscope. 
GFP and dsRed expression were viewed with the help of a 
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mercury light source and a FITC filter set and a TRITC filter set 
respectively. Cerulean expression of myrAKT and KDAKT fish 
was observed with the help of a mercury light source and a 
Cyan-GFP filter set. 
All embryos were anesthetised before observing and imaging 
by adding 750µl of 4g/l pH 7-7.5 tricaine methanesulfonate 
(MS222) into the petri plate containing fish water and the 
embryos, in order immobilize them. This was necessary 
especially when the embryos were out of their chorions and 
were mobile. 
2.7. Culling of fish 
 
Since the KDAKT lines qmc171, 172 and 173 did not express 
cerulean very convincingly we decided to terminate these 
lines. Fish were put into MS222 (4g/l pH 7-7.5). The fish were 
allowed to stay in the MS222 for about 10 minutes. According 
to home office regulations, the brain of the fish must be pithed 




2.8. Adult zebrafish dissection and kidney isolation 
The method for dissection of the adult zebrafish and isolation 
of the kidney was adapted from the method described by 
Gerlach et al (Gerlach et al., 2011).  
Briefly, the fish that were to be dissected were euthanized by 
placing the fish in (MS222) (4g/L pH 7-7.5) for about 10 
minutes. The fish were then taken out of the MS222 and 
placed on an absorbent paper towel after which they were 
ready for dissection. A fish was then placed on a dissecting 
tray and the dissection was carried out under a dissecting 
microscope. The head of the fish was cut from under the 
operculum at an angle of approximately 45¡, to avoid 
rupturing the heart which if ruptured causes blood to cover 
other tissues making in difficult to view the kidney. Once the 
head was detached from the body of the fish the body of the 
fish was cut open making sure not to cut too deep which could 
damage the kidney. The fish was pinned down to the 
dissection tray and the internal organs such as the gonads, 
intestine, swim bladder were removed. The kidney was 
identified. The body of the fish with the kidney was placed in a 
container containing 4% paraformaldehyde (PFA), which was 
prepared in a 50ml falcon tube, by dissolving 2g of PFA in 
40ml of sterile water and 20µl of 1M NaOH. This was left at 
65¡C for about 2 hours and inverting the tube from time to 
time to allow the PFA to dissolve completely. Once the PFA had 
dissolved completely it was cooled to 4¡C on ice. When cool 
5ml of 10X phosphate buffered saline (PBS) pH 7.5 was added 
and the volume in the tube was brought up to 50 ml with 
distilled water. The tube was kept on ice again and 50µl of 
DMSO was added. The fish were left in this 4% PFA solution at 
4¡C overnight in order to fix the kidney.  
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The next day using 2 tweezers the kidney was carefully 
detached from the connective tissue and placed into a 1.5ml 
eppendorf tube containing 1ml of 1X PBST (1X PBS with 0.1% 
(v/v) Tween 20). This was left overnight at 4¡C. The next day 
the kidney was washed with 5%, 15% and 30% sucrose 
solution (in water) for 30 minutes each on the rocker. The 
kidney was finally suspended in a 30% solution of sucrose 
which was left at 4¡C. 
2.9. Optimal cutting temperature (OCT) compound 
embedding 
In order to carry out embedding of the kidney, it was first 
removed from the 30% sucrose solution and was moved into 
OCT compound for 30 minutes. After 30 minutes the kidney 
was removed from the OCT and placed in a mould using a fish 
pipette, however making sure not to introduce air bubbles. 
The kidney was orientated as desired and was covered with 
fresh OCT. The mould containing the kidney was left on dry ice 
for 30 minutes for quick freezing of the tissue, and was then 
moved into -80¡C overnight. 
2.10. Cryostat sectioning 
Before sectioning the kidney the Leica cryostat was switched 
on and the temperature set to -24¡C, it takes a few hours for 
this temperature to be reached. Once the cryostat has 
attained the desired temperature, the mould containing the 
frozen kidney was removed from the -80¡C freezer. The OCT 
block in which the kidney embedded was detached from the 
mould and placed on the chuck in the cryostat machine and 
sectioned at 10 micron (µ) sections. Once cut the sections 
were placed on superfrost (++) slides. The slides were left on 
a heat block at 37¡C for 30 minutes, in order to dry them. 
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After 30 minutes the slides were placed in a slide box and 
could be stored at -20¡C indefinitely. 
2.11. Immunohistochemistry on kidney sections to 
detect GFP and dsRed 
2.11.1. Treating sections with the primary antibody for 
detection of GFP and dsRed positive cells 
The day slides were to be stained they were removed from the 
-20¡C freezer and were allowed to thaw for 5 minutes before 
they were washed in a Coplin jar with incubation solution 
(1XPBS; 1%DMSO and 0.5%Tween20) for 30 minutes. This 
was followed by washing the slides with 3% H2O2 (in 
methanol). This was done in a Coplin jar and left for 30 
minutes on the rocker. After 30 minutes the slides were 
removed and the 3% H2O2 was replaced with tap water in 
which the slides were rinsed, another wash of 5 minutes in 
incubation solution was followed before the slides were treated 
with blocking solution. Blocking solution was made using PBS 
(1X), DMSO (1%), Tween 20 (0.5%), Bovine serum albumin 
(BSA) (1%) and goat serum (10%), 500µl of blocking solution 
was added to each slide and the slides were incubated in a 
humidified chamber for 2 hours. 
After 2 hours the slides were drained on a paper towel and the 
primary antibody was added which was diluted 1:250 in a 
solution consisting of PBS (1X), DMSO (1%), Tween20 (0.5%), 
Goat serum (2%) for the GFP the antibody used was an anti-
GFP goat polyclonal antibody (biotin) from abcam (ab6658). 
The primary antibody used for detecting dsRed was a 
polyclonal antibody rabbit antisera raised against dsRed-
express from Clontech, this antibody is not biotinylated. After 
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the addition of the primary antibody the slides were incubated 
in a humidified chamber at 4¡C overnight. 
2.11.2. Washing of slides 
The next day the humidified chamber containing the slides was 
brought out and allowed to attain room temperature, The 
slides were then drained and washed using a Ôhigh-salt wash 
solutionÕ which was done in order to reduce non-specific 
binding of the antibody which could cause background. This 
solution was prepared using PBS (1X), DMSO (1%), Tween20 
(0.5%), Goat serum (2%) and 5M NaCl (0.18%). The slides 
were washed in this solution for 30 minutes in a Coplin jar 
kept on the rocker. The Ôhigh-salt wash solutionÕ was followed 
by 3X30 minute washes with incubation solution. 
2.11.3. Detection of GFP+ cells using vectastainABC kit 
followed by DAB staining 
The VectastainABC kit was used in order to detect GFP+ cells in 
the kidney. The Elite PK-6100 standard vectastainABC kit was 
used. This commercially available kit consists of 2 solutions, 
solution A is an avidin solution and solution B is a biotinylated 
enzyme. The two solutions are added in equal amounts in an 
eppendorf tube containing 1XPBS/Tween. We prepared a total 
of 1.5ml of this solution in which to 1.5ml of 1XPBS/Tween 
15µl of each of the solutions A and B were added. The tube 
was incubated at room temperature on the rocker for 
30minutes, which allows the formation of an 
avidin/biotinylated enzyme complex (ABC). After 30 minutes 
this solution was applied to the slides that were incubated in a 
humidified chamber for 1 hour in the dark. After an hour the 
slides were drained and rinsed 3X5 minutess with incubation 
solution. After the last wash DAB solution A and B were mixed 
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we made 1.5 ml of the solution, hence to 1.5ml of solution A 
45µl of solution B was added. The DAB was purchase from 
Sigma-Aldrich. The slides were left in a humidified chamber for 
with the DAB for approximately 30 seconds. The 
avidin/biotinylated enzyme complex (ABC) which attaches to 
the GFP+ cells is detected by the DAB stain, hence showing a 
brown colour in GFP+ cells. Drain the slides and rinse with 
incubation solution 3X5 minutes. 
2.11.4. Detection of dsRed+ cells in kidney sections 
using secondary antibody followed by DAB staining 
We found that dsRed cells were detected better using a 
secondary antibody rather than the avidin/biotinylated enzyme 
complex (ABC). After the washing steps (2.10.2.) a secondary 
antibody which was an anti-rabbit IgG peroxidase conjugate 
(Sigma Aldrich) was added which was first diluted 1:300 in a 
solution containing PBS (1X), DMSO (1%), Tween20 (0.5%), 
goat serum (2%). After the addition of the secondary 
antibody, the slides were incubated in a humidified chamber 
for 2hours in the dark. After 2hours the slides were drained 
and washed 3X30 minutes in incubation solution. DAB was 
prepared and added as done above (2.10.3.). However the 
incubation time required for staining dsRed+ cells with DAB 
stain was longer around 5 minutes. After 5 minutes the DAB 
was drained from the slides and the slides were rinsed 3X5 
minutes with incubation solution. 
2.12. Observation and documentation of sections on 
slides 
Before the slides were observed a few drops of 80% glycerol 
was added to the slides, a coverslip was put on the slides and 
the slides were observed under the bright field compound 
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microscope Nikon Eclipse 80i using the DIC optics. Images 




Chapter 3. Introduction to lineage tracing of 
haematopoietic stem cells (HSCs) 
3.1. Lineage tracing of cells 
A single cell can give rise to a number of cells. Lineage tracing 
would be the identification of the progeny of a single cell 
(Kretzschmar and Watt, 2012). Lineage tracing or fate 
mapping has become a major part of stem cell biology studies 
and helps biologists gain insights into properties of tissues. 
This process provides a means of studying the cellular origin of 
cells. 
Lineage tracing can be done in a number of ways both in mice 
as well as in fish. Strategies of lineage tracing could involve 
both short term as well as long-term tracing. For a more 
detailed review of different lineage tracing methods refer to 
(Kretzschmar and Watt, 2012). 
3.1.1. Short-term lineage tracing of cells 
Short-term lineage tracing includes the use of laser-activated 
dyes to label cells. Short-term experiments using such dyes 
were used in zebrafish to show that cells leaving the vDA so 
indeed migrate to the CHT and eventually seed the thymus as 
we as the kidney (Jin et al., 2007; Murayama et al., 2006).  
3.1.2. Long-term lineage tracing of cells 
Methods used for long term lineage tracing both in murine and 
fish systems include tracing by genetic recombination. The Cre 
loxP recombination system has been used for genetic 
recombination and has proven extremely efficient in mouse. 
Hans et al (2009) have shown that the Cre/loxP system is 
indeed a good tool to carry out recombination even in the fish 
(Hans et al., 2009). 
  
29 
Cre recombinase catalyses the deletion (usually) of the floxed 
region to express a protein downstream. A floxed region is the 
region that is flanked by two loxP sites (Fig. 1). Bertrand et al. 
(2010) have used a constitutively active Cre protein to trace 
cells from the early embryo to the adult kidney marrow 






Fig. 1: Illustrates the recombination event: Where Cre 
recombinase excises the region between two lox P sites (GFP 
is excised) to express the protein (dsRed). Before the 
recombination event the EGFP reporter is under the control of 
the promoter (ef1α promoter). After recombination the EGFP 
that is floxed gets excised thus expressing the second reporter 
(dsRed). The expression of dsRed is under the control of the 
ef1α promoter. 
The Cre/loxP recombination system could either be 
constitutively active or inducible. A constitutively active Cre 
protein carries out recombination throughout and can be only 
spatially controlled by using a tissue specific promoter. 
However, temporal and special control of Cre activity can be 
controlled with an inducible system. Spatial control can be 
included by using a tissue specific promoter, for example flk1 
promoter to drive expression in endothelial cells. Temporal 
control can be given by fusing the Cre protein to the human 
eastrogen receptors (ERT2), which in the absence of a ligand, 
like the drug tamoxifen or its active metabolite-
hydroxytamoxifen (4-OHT) is kept in the cytoplasm by the 
(heat shock promoter) hsp90. In the presence of the ligand 
(tamoxifen or 4-OHT) ERT2 binds to the ligand hence causing 
a conformational change and activation of the ERT2 which now 
bound to the ligand translocates to the nucleus, leaving the 
hsp protein in the cytoplasm. In the nucleus Cre thus 
recombines the loxP sites (Kretzschmar and Watt, 2012) (Fig. 
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6I) We have used this system in our experiments and will look 
at the Cre/lox P system with respect to our experiments. 
3.2. Migratoy route of HSCs during definitive 
haematopoiesis 
In the developing zebrafish embryo, during the second or 
definitive wave of haematopoiesis, cells appear from the 
ventral wall of the dorsal aorta (vDA) that are putative HSCs 
and are identified by the expression of the transcription factors 
runx-1 and c-myb. These cells first emerge in the vDA just 
before the primitive erythrocytes enter circulation around 24 
hours post-fertilisation (hpf) (Gering and Patient, 2005). They 
then migrate to the caudal haematopoietic tissue (CHT) at day 
1 post fertilization (1 dpf) to 7 dpf (Ellett and Lieschke, 2010), 
here they expand and differentiate before migrating to seed 
the kidney and the thymus (Fig. 2.I) The thymus is colonised 
by T and B cells (Willett et al, 1999, Lieshke et al 2001, Lin et 
al 2005) and seems to be the seeding and maturation site for 
lymphocytes (Menke et al 2011) while the HSCs from the CHT 
seed the kidney from 4 dpf (Ellett and Lieschke, 2010). The 
kidney and the thymus are the sites of larval and adult 










Fig. 2. I: Migration of cells that express the transcription 
factor c-myb. In-situ hybridisation done on the developing 
zebrafish embryo for c-myb positive cells that are formed in 
the (A) vDA at 24 hpf, also observed are a population of c-
myb positive cells which are most likely to be erythromyloid 
progenitors and primitive red blood cells in the posterior blood 
islands (PBI) (circled purple) (B) the c-myb positive cells 
migrate from the vDA to the caudal haematopoietic tissue 
(CHT) (green arrow; in-situ experiments carried out on 34 hpf 
embryo) (C) In a 3 dpf embryo, cells in the CHT multiply and 
migrate to (D) the thymus (small blue arrows) and the kidney 
(red arrow; in situ carried out on a 5 dpf embryo). (Fig.1 I 
Supplied by Dr. Martin Gering and was modified)   
II: Schematic representation of the timeline of 




3.3. Generation of the Tg(flk1CreERT2)qmc104 line. 
Previous work done in the lab included the cloning of the 
Flk1/kdrl:eGFP transgene into a Tol2 vector fragment (Fig. 3 
A). This construct carries a 0.8kb flk1/kdrl enhancer and a 
1.5kb flk1/kdrl promoter that drives expression of an 
enhanced green fluorescent (EGFP, more commonly known as 
GFP) reporter. The expression pattern of flk1:GFP is depicted 
in (Fig.3 B and C) where flk1:GFP labels the endothelium and 
the endocardium in the developing embryo. 
 
Fig. 3: Expression pattern of flk1/kdrl GFP in qmc 67 
which is governed by the flk1 promoter and enhancer.  
(A) The flk1:GFP construct that shows the 0.8 kb enhancer 
and 1.5 kb promoter fragment  
(B and C) GFP as seen at 14s (somite stage) (16 hpf) and 23 
hpf in the developing zebrafish embryo. (C) flk1:GFP is 
expressed in the dorsal aorta (red arrow), in the vein (blue 
arrow), in intersomatic vessels (pink arrows) and in the 
endocardium (orange arrow).  
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The Cre repoter line was received from Bally-CuifÕs lab in Paris. 
Fish that carry only the Cre reporter transgene express GFP 
ubiquitously and not dsRed (Fig. 4). GFP expression is under 
the control of the ef1α promoter. In the event of 
recombination of the loxP sites, in this construct there will be 
expression of dsRed, which again would be under the control 
of the ef1α promoter.  
Two constructs were generated that made use of the same 
flk1 promoter and enhancer fragment (Fig. 3A) to drive Cre 
(Fig. 5 A and B). We expect the flk1 promoter and enhancer to 
drive Cre in the similar manner as it drives GFP in endothelial 
and endocardial cells (Fig. 3B and C). These two constructs 
were then injected into wt embryos. The first was a flk1Cre 
line, also called as the qmc101 that has a frame shift between 
Cre and ERT2 and hence is constitutively active and not 
inducible. As we progress through the text this line would be 
referred to as flk1Cre(qmc101) (Fig. 5A). The second is an 
inducible flk1CreERT2 line. This line is an inducible line and 
hence would be dependent on the presence of the ligand 4-





Fig. 4: Cre reporter embryos express GFP ubiquitously 
and do not express dsRed. 
Embryos express only GFP and no dsRed expression is seen in 
these embryos. Auto-fluorescence seen in the yolk sac (blue 
arrow) and in some pigment cells (yellow arrow).  (Picture of 
























Fig. 5: Different lines generated using the flk1 enhancer 
and promoter. 
A) The flk1CreXERT2 qmc101  there is a frame shift between 
Cre and ERT2 and hence the Cre is constitutively active and 
not inducible.  ÔXÕ indicates the frame shift between Cre and 
ERT2. 
B) The qmc 104 line an inducible Cre fused is to the human 
oestrogen receptor (ERT2). Hence in order to carry out 
recombination the Cre is dependent on tamoxifen or its active 
metabolite 4-hydroxy tamoxifen. 
C-D) when the flk1Cre transgenics were crossed with Cre 
reporters some of the progeny that were GFP positive (C) also 
expressed dsRed on 5 dpf, in the CHT (white arrows), in 
intersomitic vessels (blue arrows), in the thymus (purple 
arrow) and in the endocardium (yellow arrow). This is the qmc 




As explained earlier recombination of the loxP sites takes place 
under the control of the flk1 promoter which is a tissue specific 
promoter, specific to endothelial cells, hence provides the 
spacial control in our lines. In the absence of 4-OHT the 
CreERT2 is retained in the cytoplasm by the hsp90 protein, 
which is bound to CreERT2. In the presence of the drug 4-
OHT, which is a ligand for the CreERT2 fusion protein ERT2 
binds to the ligand and translocates from the cytoplasm to the 
nucleus where Cre catalyses recombination (Fig. 6 I). 
 
 
Fig. 6: CreERT2 recombination system: I Schematic 
representation of the mechanism of temporal control of 
recombination by the ligand 4-OHT in cells of the green-to-red 
reporter line. II) Schematic diagram of the recombination 
event. In the absence of Cre the ef1α promoter drives GFP 
expression that changes to dsRed after a successful Cre 
mediated recombination of the loxP sites (figure modified from 
Hans et al, 2009).  
  
39 
When the flk1CreERT2 fish were crossed to the Cre reporter 
line, after a successful recombination event in the presence of 
4-OHT (Fig. 7A, B and C), dsRed is expressed which is under 






Fig. 7: Schematic representation of recombination of the 
loxP sites in the presence of 4-OHT in the Flk1CreERT2 
line 
A) The Cre reporter construct  
In order to recombine the flk1CreERT2 the SN9 fish were to be 
crossed with the Cre reporter (SN41) that have the transgene 
(ef1α-loxP-GFP-terminator-loxP-dsRed). The embryos from 
this cross were then treated with 4-hydroxy tamoxifen (4-
OHT), an active metabolite of the drug Tamoxifen 
D) dsRed expression seen on 5 dpf embryos that were the 4-
OHT  treated progeny of the flk1CreERT2 transgenics that 
were crossed to the Cre reporters. This is the qmc 104 line. 
Expression in the CHT (blue arrows) was weak and only in a 
few cells, expression in the intersomitic vessels was 




Dr. Martin Gering had injected wt embryos with the 
flkiCreERT2-HA.M transgene, coinjected with the transposase 
mRNA (Fig. 8) in April 2011. These embryos were grown up 
under the stock number SN9. After 3 months when the 
embryos were adults and were ready to be bred, they were 
crossed to the Cre reporters. This led to the identification of an 
F0 SN9 fish ♀2L that carried the flk1CreERT2 transgene. This 
SN9 ♀2L was crossed with a Cre reporter fish. The embryos 
were then treated with 4-OHT at 10 hpf to induce 
recombination in the endothelium and HSCs. After treatment 
with 4-OHT, on 5 dpf 10% of the GFP positive embryos 
showed dsRed expression in the vasculature confirming 
recombination of the flk1CreERT2 transgene in the 
endothelium and in HSCs. These embryos that expressed both 
gfp and dsRed were grown up in the nursery under the stock 
number SN51 and this new line generated was called qmc104 
(Fig. 8).  
The SN numbers are the stock numbers that define a batch of 
embryos that have the same date of birth and same genetic 
modification (genotype).  This number is unique to every 
batch of embryos. A qmc number is assigned to a batch of 
embryos that carry the same transgene in an identical 






Fig. 8: Schematic illustration of the SN9 F0 fish (♀2L) 
that was the founder of the qmc104 (flk1CreERT2) line. 
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Murayama et al in 2006 injected a caged dye, used a laser to 
uncage the dye, thus tracking the migratory route of the cells 
that emerged from the vDA to the definitive haematopoietic 
organs, the thymus and the kidney. However the method used 
by them, had 2 drawbacks, 
a) They were able to track cells only until 5 dpf of the 
developing embryo and not until adulthood. 
b) During uncaging of the tracking dye while trying to target 
cells only of the endothelium, neighbouring cells from other 
tissues could also get activated and uncaged, making it 
difficult to distinguish been different cells. 
Bertrand et al (2010), using a constitutively active flk1Cre, 
lineage traced dsRed positive cells from an endothelial origin, 
i.e. cells that expressed flk1, in the developing zebrafish 
embryo and showed that these cells made up all of the kidney 
marrow cells in the adult fish. However using a constitutively 
active Cre protein (Fig. 9) Bertrand et al could not claim that 
all cells that seed the adult kidney came from the early 
embryo alone. Their experiments raised further questions of 
whether or not there were HSCs that formed at a later time 
point other than the expected EHT time? From their 
experiments they could not rule out it that if flk1 was 
expressed at some other time point during development in 
some mersodermal cell (Fig. 10 circled orange), or if an HSC 
at any time during development switched ÔonÕ flk1, then in 
fact, they could not claim that all cells that seed the adult 
kidney came from the early embryo alone.  
3.4. Aims and objectives 
For the characterisation of CreERT2 founder lines we have 
labelled cells by inducing with 4-OHT at different time points 
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during embryonic development.  Since lineage tracing 
experiments are long term experiments, only a part of this 
was done. During this project, we aim to establish methods to 
isolate, section and stain the adult zebrafish kidney. 
 
 
Fig. 9: Recombination system described by Bertrand et 
al (2010): Where the constitutively active Cre protein is 
under the control of the flk1 promoter. Their Cre reporter has 
a β-actin promoter up front and a super stop cassette is 
floxed. In the event of recombination the loxP sites are 
recombined and the superstop cassette is excised hence giving 
expression of the dsRed which is under the control of the β-







Fig. 10: Illustrates the development of HSCs in 
Definitive Haematopoiesis 
So far it has been shown that the route of HSC development 
and formation is initiated in the mesoderm in the early embryo 
which gives rise to hemangioblasts. Hemangioblasts then give 
rise to primitive RBCs and flk1 positive arterial endothelial 
cells. HSCs emerge from the flk1 positive hemogenic 
endothelium of the ventral wall of the dorsal aorta (vDA). 
These HSCs that emerge from the vDA migrate to the caudal 
haematopoietic tissue (CHT) and then to seed the kidney 
marrow which is the site of adult haematopoiesis. 
Could there be the possibility of an HSC being formed from a 




Chapter 4: Results 
4.1. Identification of SN9 F0 parental fish that carry the 
flk1CreERT2 transgene in their germline and generation 
of flk1CreERT2 transgenic lines 
Previously in the lab an inducible flk1CreERT2 construct (Fig. 
5b) was made and injected into wt embryos which were grown 
up under the stock number SN9. The flk1 promoter and 
enhancer have been shown to drive expression of a reporter 
protein; green fluorescent protein (GFP) in the endothelium 
and the endocardium (Fig. 3). We therefore expected flk1 to 
drive recombination in a similar manner in our flk1CreERT2 
line. Recombination of the loxP sites should occur in 
endothelial as well as in endocardial cells only in the presence 
of the drug Tamoxifen or its active metabolite 4-
hydroxytamoxifen (4-OHT).  
Identification of the SN9 fish was carried out, by checking for 
the presence of the flk1CreERT2 transgene. It might be worth 
mentioning here, that the SN9 fish, if at all, would carry only 
the flk1CreERT2 transgene, and not the Cre reporter. Hence in 
order to identify carriers of the flk1CreERT2 transgene 
amongst the SN9 fish, these were crossed to wt fish and 
genomic DNA was isolated (Table 1) from the embryos 
obtained. Using primer number 143 (forward primer) and 144 
(reverse primer) the 592bp fragment (flk1CreERT2) was 
identified, which thus confirmed the presence of the transgene 
in potential carriers among the SN9 fish.  Undergraduate 
students, Helen Swan, Chandni Modha, Margaritta Ruivo and 
Vicki King who I supervised for their 3rd year projects were 
involved in setting up some crosses. Mohammad Al Khamees a 
1st year PhD student was also involved in setting up crosses.  
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2 positive controls were also set up (Fig. 11 lane 1 and lane 
2), along with the test samples.  Positive controls included 
DNA isolated from embryos from known flk1CreERT2 carriers. 
Both controls showed bands at the 592bp position (Fig. 11). 
The control in Lane 1 (Fig. 11) contained DNA isolated from 
embryos obtained from the founder (SN9♀2L) of the qmc104 
line, hence we already know that this fish carries the 
flk1CreERT2 transgene, however only 10% of its germline is 
transgenic, due to which 10% of embryos from this fish would 
be transgenic (Fig. 8). This would explain the lower band 
intensity level in lane 1 as compared to lane 2 (Fig. 11). Lane 
2 (Fig. 11) comprised of DNA that was isolated from embryos 
from the qmc 101 line (Fig. 5A) that carried a constitutively 
active Cre protein. The qmc101 fish used to obtain embryos 
for DNA isolation were F1 fish that gave 50% transgenic 
embryos. Hence the higher percentage of transgenic embryos 
used could explain why the band in Lane2 was stronger than 
the band in Lane1 (Table 1 and Fig. 11). 
Lanes 12 and 13 were negative controls (Fig. 2 lane12 and 
lane 13). Lane 12 contained DNA from flk1GFP embryos and 
Lane13 contained no DNA, it was a water control, which was 
done, in order to rule out any contamination introduced while 
pipetting or through other reagents and/or from the water that 







Table 1: Depicts the SN9 fish that were identified as 
potential carriers of the flk1CreERT2 transgene by PCR, 
the number of embryos used from each fish to isolate 
genomic DNA and the PCR result. 
Lane/Well 
number 
Fish and line 
numbers 
Number of embryos 












3 SN9♀1 73 very weak 
4 SN9♂1 54 very weak 
5 SN9♂2 45 weak 
6 SN9♂4 65 weak 
8 SN9♂5 61 bright 
band/ 
PCR+ 
9 SN9♂6 78 bright 
band/ 
PCR+ 
10 SN9♂7 60 no band 
11 SN9♂8 77 bright 
band/ 
PCR+ 
12 flk1:GFP (negative 
control) 
- no band 
13 water control 
(negative control) 







Fig. 11: Primary identification of SN9 fish by PCR. 
Agarose gel showing lanes 1 to 13. Lanes 1 and 2 had the 
positive controls (circled blue) and show bright bands on the 
gel at the 592bp position. Lanes 3, 4, 5 and 6 showed weak 
bands (circled yellow). Lane7 displays the 1kb ladder, where 
the 0.5kb and 1kb bands have been labelled. Lanes 8, 9 and 
11 contained DNA from SN9 fish ♂5, SN9 ♂6 and SN9 ♂8 
respectively, that gave bright bands (circled red) at the 592bp 
position. Lane 10 showed no band at the 592bp position; 
hence SN9♂7 did not carry the flk1CreERT2 transgene. Lanes 
12 and 13 were negative controls and showed no bands at the 
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From Fig. 11 we observed that 3 fish are potential carriers of 
the flk1CreERT2 transgene among the SN9 fish that were 
tested and they were SN9 ♂5, SN9 ♂6 and SN9 ♂8, this 
excludes the SN9♀2L that had already been identified as a 
flk1CreERT2 carrier and was the founder of qmc104. A 
pedigree of the SN9 fish that have been identified as potential 
carriers for the flk1CreERT2 transgene has been illustrated in 
Fig. 12  It was observed that genomic DNA isolated from the 
embryos of these fish gave the brightest bands at the 592bp 
position. When these bands are compared to a 1kb DNA 
ladder, it was observed that they lie between the 0.5kb and 
1kb fragments, hence suggesting that these fish carried the 
flk1CreERT2 transgene. SN9♂2 and ♂4 showed slightly weak 
bands, however SN9♂7 showed no band (Fig. 11) at the 
592bp position, hence indicating ♂7 was not a carrier of the 
flk1CreERT2 transgene (Table 1). 
Once we had identified 3 potential carriers of the flk1CreERT2 
transgene among the SN9 fish, namely SN9 ♂5, ♂6 and ♂8, 
we then crossed them to the Cre reporter line (SN41) in order 
to be able to detect the activity of the Cre. The SN41 fish were 
heterozygous carriers for the transgene ef1α-loxP-GFP-
terminator-loxP-dsRed therefore we expect 50% of the 
progeny to be GFP positive. Depending on what percentage of 
the germline of these SN9 F0 fish was transgenic (had the 
flk1CreERT2 transgene), we would expect a percentage of the 
embryos to carry out recombination in the presence of 4-OHT 
and express dsRed. The embryos were treated with 5µl of 
2.5mM 4-OH from tailbud stage (10hpf), in order to induce 
recombination.  
We treated all of the embryos, from each cross with 4-OHT 
and left no embryos untreated from any batch. We did this 
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since we were not sure about what percentage of the germline 
of each of these fish was transgenic. Hence, what percentage 
of embryos obtained from these fish would be transgenic 
(carry the flk1CreERT2 transgene) considering the fact that 
these fish were F0 fish. Thus if a fish had a very small 
percentage of its germline to be transgenic, treating all the 
embryos with 4-OHT increased our chances of identifying a 
transgenic fish. GFP expression was ubiquitously seen in 
embryos on 1 dpf. Choi et al. (2007) have reported that GFP 
expression driven by flk1 can be detected by the 8 somite 
stage of embryonic development (Choi et al., 2007).  
Ubiquitous expression of GFP is seen on 1dpf and is driven by 
the ef1α promoter. Recombination of the loxP sites takes place 
under the control of the flk1 promoter, which is a tissue 
specific promoter, specific to endothelial and endocardial cells. 
Therefore, we expect recombination to occur in endothelial 
cells and endocardial cells and any cell that would express flk1 
at that time point during treatment with 4-OHT (in our case 
from day0 to day5). Recombination results in dsRed 
expression from late 4 dpf to 5 dpf in the endothelium and 
endocardium of the developing embryo. dsRed expression is 
under the control of the ef1α promoter.  The reason for the 
delay in dsRed expression is because a lot of dsRed mRNA 
needs to be translated in order to make a sufficient amount of 
the fluorescent protein that can be visualised (Drew, MSci 
2010) under the microscope. Therefore even though 
recombination takes place much earlier on in the developing 
embryo the dsRed fluorescence is only seen after 4 dpf (Drew, 




Table 2: Represents the SN9 fish that gave weak or 
strong band on PCR analysis and were crossed to the 
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Fig. 12: Illustrates the pedigree of the SN9 F0 fish that 
were carriers of the flk1CreERT2 transgene and hence 
were founders of the various qmc lines  
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SN9♂8 is the founder of qmc105. All 69 embryos were treated 
with 4-OHT (Table 2). 6.3% of the germline of this fish was 
transgenic (Table 2). We know this because 2 out of 32 GFP 
positive embryos (Fig. 13) carried both the transgenes, the 
flk1CreERT2 and the Cre reporter, and in the presence of 4-
OHT carried out site specific recombination in the endothelium 
and in the endocardium to express the red fluorescent reporter 









Fig. 13: Progeny of SN9♂8, qmc105. Pictures were 
taken with a wild type (wt) embryo from the same batch 
that were treated with 4-OHT.All pictures were taken at 4 
dpf 
A) Bright field (BF) image of a qmc105 embryo with a wt 
embryo,  
B) the image was taken in the green channel with a black 
and white camera and was later pseudocoloured green. 
The GFP positive embryo is qmc105. 
Ci and Cii) were taken in the red channel and were 
photographed using a black and white camera. The red 
pseudocoloured image was not of a very good and 
convincing quality hence were left in black and white which 
looks much better. Ci) shows a qmc105 embryo and a wt 
embryo the heart (green arrowhead) showed dsRed 
positive cells, thymus (white arrow) expressed dsRed. 
Caudal haematopoietic tissue (CHT) (red boxed area) 
magnified in Cii. Cii shows the CHT containing dsRed 
positive cells (white arrowhead) and also shows 





From the cross SN9♂6 with the Cre reporter line a total of 303 
embryos were treated with 4-OHT. 140 of these were only GFP 
positive embryos and 21 were double positive embryos. 13% 
of the germline of SN9♂6 was transgenic (Table 2). This 
means that these 21 embryos had done the recombination in 
the endothelium and hence expressed both GFP as well as 
dsRed. However, 10/140 embryos showed ectopic expression 
(Table 2) in the brain, somatic muscle cells and neural crest 
(Fig. 14 aiii, aiv, av and avi) in addition to the normal 
expression pattern seen in endothelial cells which includes 
CHT, thymus, intersomitic vessels and the heart (Fig. 14 aiii, 
aiv, av and avi). Ectopic expression is seen in an abnormal 
place in the embryo. This could be because, when SN9♂6 was 
injected as an embryo, the transposon might have jumped into 
the vicinity of an enhancer that drives expression in the brain 
and somatic muscle cells. These 10 embryos were given a new 
line number, qmc107, but this line was not maintained due to 
the dsRed expression that was seen ectopically. 
The same cross, SN9♂6 to the SN41 fish also had 11/140 
embryos (Table 2) that did the recombination only in the 
endothelium, and gave the normal expression pattern of 
dsRed, which was seen in the CHT, thymus, intersomitic 
vessels and the heart (Fig. 15 Biii and Biv). These 11 embryos 
were grown up under a new line number, qmc 109. Therefore 
SN9♂6 is the founder of 2 lines, qmc 107 and qmc109, and 
the expression pattern differences can be observed in (Fig. 16 
Aiii). 
The fact that the progeny of SN9♂6 displayed different 
expression patterns could suggest that this is due to the 
presence of multiple copies of the flk1CreERT2 transgene. 
  
57 
Fig. 14: Progeny of SN9♂6, qmc107. Pictures were taken 
with a wild type (wt) embryo from the same batch that 
were treated with 4-OHT. All pictures were taken on 4 
dpf 
ai) Bright field (BF) image of a qmc107 embryo with a wt 
embryo  
aii) the image was taken in the green channel with a black and 
white camera and was later pseudocoloured green. The GFP 
positive embryo is qmc107.  
aiii-av) were taken in the red channel and were photographed 
using a black and white camera. The red pseudocoloured 
image was not of a very good and convincing quality hence 
were left in black and white which depicts dsRed positive cells 
much better. aiii) shows a wt embryo as a negative control 
and a qmc107 embryo that had ectopic dsRed expression in 
the neural Crest and in the somatic muscle cells and as part of 
the normal expression pattern shows dsRed expression in the 
heart, thymus and Caudal haematopoietic tissue (CHT). aiv) 
shows a magnified version of the head region of qmc107 
expressing dsRed positive cells ectopically in the neural Crest 
and in the somatic muscle cells  and as part of the normal 
expression pattern shows dsRed expression in the heart and 
thymus. av) shows a magnified image of the trunk and part of 
the tail region where dsRed positive cells where expressed 
ectopically in the somatic muscle cells and normal dsRed 
expression was observed in cells in the CHT and in intersomitic 
vessels.  
avi) shows a qmc107 embryo taken in the red channel. A 
different camera was used to take this coloured image. dsRed 
positive cells were expressed ectopically in the neural Crest 
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and somatic muscle cells and normal dsRed expression was 
observed in cells in the CHT, the heart and the thymus. Neural 
Crest (cyan arrowhead) somatic muscle cells (yellow 
arrowhead) heart (green arrowhead), and Caudal 








Fig. 15: Progeny of SN9♂6, qmc109. Pictures were taken 
with a wild type (wt) embryo from the same batch that 
were treated with 4-OHT.All pictures were taken at 4 
dpf  
Bi) Bright field image of a qmc109 embryo with a wt embryo,  
Bii) the image was taken in the green channel with a black and 
white camera and was later pseudocoloured green. The GFP 
positive embryo is qmc109. Images  
Biii and Biv) were taken in the red channel and were 
photographed using a black and white camera. The red 
pseudocoloured image was not of a very good and convincing 
quality hence were left in black and white which depicts the 
dsRed positive cells more convincingly. Biii) shows a qmc109 
embryo along with a wt embryo as a negative control. In the 
qmc109 embryo the heart (green arrowhead) expressed 
dsRed, the thymus (white arrow) showed dsRed expression 
and the CHT expressed dsRed positive cells (white 
arrowhead), the CHT is magnified in Biv. Biv) shows the CHT 
containing dsRed positive cells (white arrowhead) and also 
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Fig. 16: Depicts the comparison between the 2 lines 
established by SN9♂6, namely qmc107 and qmc109 
Ai) A Bright field (BF) image of qmc107 and qmc109 embryos, 
 Aii) the image was taken in the green channel with a black 
and white camera and was later pseudocoloured green. Both 
lines, qmc107 and qmc109 expressed GFP ubiquitously.  
Aiii) was taken in the red channel and was photographed using 
a black and white camera. The red pseudocoloured image was 
not of good quality hence was left in black and white which 
depicts the dsRed positive cells more convincingly. (Aiii) shows 
the expression pattern differences between qmc107 and qmc 
109 embryos. Both embryos expressed dsRed in the heart 
(green arrowhead), the thymus (white arrow) and showed 
dsRed positive cells (white arrowhead) in the CHT. Qmc 107 
also showed ectopic expression in the somatic muscle cells 
(yellow arrowheads) and in the neural Crest (cyan arrowhead). 
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All of the 221 embryos were treated with 4-OHT when they 
were at around 11-12 hpf (3-6 somite stage). 138 embryos 
were only GFP positive and 83 embryos were GFP negative 
(Table 2). Only 1 embryo out of 139 GFP positive embryos 
showed dsRed expression in the endothelium on 4 dpf (Fig. 
17C). Hence 0.7% of the germline of SN9♂5 carried the 
flk1CreERT2 transgene. The single dsRed positive embryo was 
given a new line number; qmc110 and SN9♂5 was the founder 
of qmc110. Unfortunately this embryo did not survive and 
hence the line qmc110 was discontinued. dsRed expression 
was not only observed in 1/139 embryos but the dsRed 
expression observed was relatively weaker (Fig. 17C and D) 
with only a few cells expressing dsRed in the CHT and a few 
intersomitic vessels when compared with embryos that 
expressed dsRed, obtained from SN9♂6 and ♂8, namely 
qmc105, qmc107 and qmc109. Qmc110 did not express dsRed 
very convincingly in the heart nor in the thymus (Fig. 17C). 
This could either be due to the lesser copy number of the 
flk1CreERT2 transgene present as compared to that present in 
the other 2 fish SN9♂6 and ♂8. Another reason for the weak 
expression seen in the qmc110 could be that the flk1CreERT2 
transgene could have jumped in a region of a regulatory 








Fig. 17: Progeny of SN9♂5, qmc110. Pictures were taken 
with a wild type (wt) embryo from the same batch that 
were treated with 4-OHT.All pictures were taken at day 
4 dpf  
A) Bright field (BF) image of a qmc110 embryo with a wt 
embryo,  
B) The image was taken in the green channel with a black and 
white camera and was later pseudocoloured green. The GFP 
positive embryo is qmc110. This image was taken at a high 
exposure time and hence looks over exposed. The qmc110 
embryo was photographed along with a wt embryo as a 
negative control. 
C and D) were taken in the red channel and were 
photographed using a black and white camera. The red 
pseudocoloured images were not of good quality hence were 
left in black and white which depicts the dsRed positive cells 
more convincingly. In the qmc110 embryo the heart did not 
express dsRed very convincingly and nor did the thymus. The 
CHT in this line expressed very few dsRed positive cells (white 
arrowhead) as compared to the other lines, the CHT is 
magnified in image D. D) shows the CHT containing very few 
dsRed positive cells (white arrowhead) a few intersomitic 









Together in this experiment we identified 3 SN9 (F0) fish that 
had the flk1CreERT2 transgene and from these we established 
4 lines qmc105, qmc107, qmc109 and ectopic qmc110. 
However qmc107 gave ectopic expression in the neural Crest 
and in somatic muscle cells and hence embryos of this line 
were not grown up. Qmc110 was a single embryo and 
unfortunately did not survive. Hence only 2 lines are currently 
growing up namely qmc105 and qmc109. 
The reason for crossing the SN9 fish was to identify F0 
founders and use them to generate and maintain flk1CreERT2 
lines in the future. We had the SN51 qmc104 line which was 
the F1 generation of the SN9♀2L to work with for our lineage 
tracing experiments (our next step). However just in case the 
SN51 fish did not give us a single non-leaky line we would still 














4.2. Identification of SN51 F1 filial fish of the 
flk1CreERT2 qmc104 that give rise to progeny in which 
Cre activity is strictly controlled by the presence of 4-
OHT- the derivation of line qmc106  
In order to carry out lineage tracing experiments it was 
important to first essential characterise and identify at least a 
single fish that carried out recombination only in the presence 
of the ligand 4-OHT and not otherwise.  
As discussed in Chapter 3, the SN51 or qmc104 fish was a line 
established by crossing the SN9 fish to the Cre reporter line 
(SN41). The founder of this line was the SN9♀2L. The 
CreERT2/loxP system is a valuable and efficient tool used to 
carry out site specific recombination. It has been widely used 
in the mouse but Hans et al (2010) have shown that this 
system is in fact extremely efficient even in the zebrafish. We 
decided to confirm this using our SN51 fish. 
We know from previous work done in the lab that 10% of the 
SN51 GFP positive embryos were also dsRed positive and had 
carried out recombination in the endothelium. Hence further 
characterisation of the SN51 fish was carried out. A pedigree 
of the SN51 fish that were characterised is illustrated in Fig. 
18 Since the SN51 fish carry the flk1CreERT2 transgene that is 
inducible, embryos from this line should carry out 
recombination only in the presence of the drug tamoxifen or 
its active metabolite 4-OHT. The latter was used to induce 










In an inducible CreERT2 system recombination should not 
occur in the absence of the ligand 4-OHT (Fig. 19). However, if 
recombination did occur in the absence of the ligand, it could 
be due to too much of CreERT2 being present in the cytoplasm 
that the hsp90 protein cannot hold back, which could 
overwhelm the cellular mechanism thus causing the CreERT2 
to escape into the nucleus. In a normal inducible system 
recombination occurs specifically in the tissue of interest, in 
our case since the flk1 promoter drives the CreERT2, 
recombination should take place only in the endothelium and 
in cells that express flk1. Since the line has an inducible Cre 





Fig. 19: Absence of dsRed expression in embryos from 
SN51♀4  that were not treated with 4-OHT 
A-C) Images were taken on 6 dpf. 
A) Bright field image of an embryo not treated with 4-OHT. 
B) Image of the same embryo as seen in the green channel, 
shows ubiquitous GFP expression. 
C) No dsRed expression observed in this embryo. Auto-
fluorescence (white arrow) seen in the yolk sac.   
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Our aim was to identify a fish among the SN51 qmc104 fish 
that carried out recombination in endothelial and endocardial 
cells, only in the presence of the ligand 4-OHT.  
Since the SN51 fish already carried both the flk1CreERT2 as 
well as the Cre reporter transgene, we crossed these to wild 
type (wt) fish, SN26. We set up 6 crosses. In order to 
characterise and identify a line that carried out recombination 
only in the presence of 4-OHT and not in its absence, it was 
important to have a control batch of embryos that were not 
treated with 4-OHT (Table 3), along with 4-OHT treated 
embryos (Table 3). This was done for each cross. The embryos 
that were treated with 4-OHT were treated when they were 
between the 10-16 hpf stage until 5 dpf. 
On 5 dpf we analysed the number of embryos from each cross 
to check for GFP and dsRed expression among embryos that 
were treated with 4-OHT and among those that were 
untreated (negative controls) (Table 3). 
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Table 3: Shows the number of embryos analysed per 
cross and indicates the number of GFP-, GFP+ only and 
GFP++ dsRed+ embryos after treatment with 4-OHT. It 
also depicts the number of GFP- and GFP+ embryos in 
the control batches that were not treated with 4-OHT 
and the number of embryos that did the recombination 































♀1 420 55 21 24 151 163 6 
♀3 403 62 33 22 143 139 4 
♀4 334 64 32 26 100 112 0 
♀5 557 97 76 24 178 181 1 
♂6 490 135 44 75 115 121 0 
♂7 289 70 23 42 78 44 32 
 
Given a scenario where a fish contains one copy of the Cre 
Reporter transgene and one copy of the flk1CreERT2 
transgene we would expect the progeny to express GFP in 
about 50% of the embryos while 50% should be GFP negative. 
Half of the GFP positive embryos should express dsRed in the 
presence of the ligand 4-OHT. Keeping this in mind we 
analysed our embryos and reasoned out a possible explanation 
for leaky expression. This helped us make a decision on which 
fish to carry out future experiments with. 
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Our numbers (Table 3) show that all crosses gave around a 
50% split of GFP positive and GFP negative embryos, which 
confirms that each fish had a single copy of the Cre reporter 
transgene. As for the flk1CreERT2 transgene, as discussed 
above, 50% of the total GFP positive embryos should be dsRed 
after treatment with 4-OHT. However, the progeny of SN51♀1 
expressed dsRed in a slightly higher number of embryos, than 
the expected 50% (Table 3). This would suggest that SN51♀1 
could have more than one copy of the transgene. The same 
was true for SN51♂6 and ♂7. The progeny of these fish too 
expressed dsRed in the presence of 4-OHT in more than 50% 
of the total number of GFP positive embryos (Table 3). This 
would suggest that SN51♂6 and ♂7 contain a multiple copy 
number of the flk1CreERT2 transgene in their genome. 
It was also observed that in some embryos from the SN51♀1, 
♀3, ♀5 and ♂7 fish there was dsRed expression even in the 
absence of 4-OHT (Table 3). Although embryos from SN51♀1, 
♀3, ♀5 that were not treated with 4-OHT gave some leaky 
dsRed expression, it was only in a few cells that recombination 
occurred (Fig. 20). SN51♂7 not only expressed dsRed in a 
high number of embryos in the absence of 4-OHT but it also 
expressed dsRed in more number of cells. This kind of leaky 
dsRed expression could suggest that there are more than one 
copy of the flk1CreERT2 transgene, especially high in SN51♂7 
and a positional effect of the transgene in these fish. We 








Fig. 20: dsRed expression seen in the progeny of 
SN51♀5 in the absence of the ligand 4-OHT (-4-OHT) 
The images were taken on 6 dpf Ai) bright field (BF) image of 
the embryo 
Aii) This image was taken in the green channel and shows a 
GFP positive embryo  
Aiii and Aiv) were taken in the red channel to view dsRed 
positive cells. 
Aiii) Shows that even in the absence of the ligand 4-OHT a few 
cells have escaped into the nucleus where they have carried 
out recombination to express dsRed (yellow boxed area). 
Aiv) The yellow boxed area in image Aiii has been magnified. A 
few dsRed positive cells (white arrowhead) were seen in the 
CHT and a few intersomitic vessels (cyan arrows) showed 




From the data obtained (Table 3) we decided that SN51♀4 was 
the best candidate to carry out time point and lineage tracing 
experiments with. SN51♀4 expressed dsRed in the 
endothelium, which includes cells in the CHT, intersomitic 
vessels and the thymus and in the endocardium (Fig. 21) only 
in the presence of the ligand 4-OHT and never in its absence 
(Table 3). This indicates that the SN51♀4 is a tight, non-leaky 
system, suitable to carry out lineage tracing experiments with. 
The numbers from this cross also suggested that this fish 
carried one copy of each of the transgenes, the Cre reporter 
and the flk1CreERT2. SN51♀4 is the founder of a new line 
qmc106. 
SN51♂6 was another prospective candidate that could be used 
for further lineage tracing experiments and was the founder of 
qmc108. The progeny of this fish did not express dsRed in the 
absence of 4-OHT (Table 3). In the presence of the 4-OHT, 
embryos from this fish expressed dsRed in the endothelium 
and in endocardial cells (Fig. 22). A few dsRed positive cells 
are seen in circulation (Fig. 22 d-e yellow arrowheads), these 
cells seem to be on the migratory route from the CHT to 
eventually seed the thymus and the kidney. However, as the 
numbers suggest (Table 3) there could be more than a single 








Fig. 21: qmc106 has a tight inducible system when 
embryos were treated with 4-OHT from late day 0 
(10hpf) to late day 5. 
Bi) Shows the qmc106 embryo taken along with a control 
embryo that was GFP positive as well 
Bii and Biii) Image was taken in the red channel to view dsRed 
expression. Bi) shows a qmc106 embryo with a negative 
control. Qmc106 shows dsRed expression in cells of the CHT 
(yellow arrows), the thymus (white arrow), while the wt 
embryo shows no dsRed expression in these areas. Bii) shows 
a close up image of the trunk region of the qmc106 embryo, 
cells in the CHT (yellow arrow) have recombined to give dsRed 
expression; intersomatic vessels (cyan arrows) also express 
dsRed and some pigment cells (white arrowheads) auto-




Fig. 22: SN51♂6 founder of qmc108 and a potential 
candidate for carrying out lineage tracing experiments 
Embryos were treated with 4-OHT and were observed and 
imaged on 5 dpf. 
a) Bright field (BF) image of qmc108 taken with a negative 
control embryo 
b) qmc108 with GFP expression as seen on 5 dpf, the wt 
embryo is GFP negative. 
c-e) images were taken in the red channel to observe for 
dsRed expression. c) shows qmc108 along with the negative 
control, qmc 108 expresses dsRed in the (c and d) thymus 
(white arrow), in the endocardium (green arrow head), in (d 
and e) in intersomitic vessels (cyan arrows) and a few dsRed 
positive cells are seen in circulation (yellow arrowheads) and 
dsRed expression seen in cells in the CHT (white arrowheads) 










Hence, in summary, this section shows the identification and 
characterisation of 2 SN51 fish, each on being a founder of a 
new qmc line. These are SN51 ♀4z founder of qmc106 and 
SN51♂6 founder of qmc108. The SN51 ♀4z and SN51♂6 both 
displayed non-leakiness and never carried out recombination 
in the absence of 4-OHT, hence displaying a tight inducible 
system.    
In order to carry out further experiments on lineage tracing 
and to check for the efficiency of our inducible CreERT2 
system we needed just a single line to work with. We thus 




4.3. Treating qmc106 embryos with 4-OHT at different 
time points during development 
We had now identified the qmc106 SN51♀4z and decided that 
it was the most suitable fish with which we could carry out our 
further experiments. 
Now, using the (2010) that carries the flk1CreERT2 transgene, 
we would like to lineage trace HSCs that arise from the flk1 
positive hemogenic endothelium of the ventral wall of the 
dorsal aorta, to seed the adult kidney. Using our CreERT2 
system we could induce recombination in these cells at 
different time points during embryonic development. Following 
induction with 4-OHT at particular time points of development 
would allow us to claim more confidently that the cells later 
seen in the adult kidney were those that did the recombination 
at the time recombination was induced.  
Hence our next step was to treat embryos obtained from a 
cross between SN51♀4z and an SN26 wt male fish with 4-OHT 
at different time points. We treated the embryos with 4-OHT 
at 2 different time points during embryonic development. One 
batch of the embryos were treated with 4-OHT from late day 0 
(10hpf) to late 1 dpf (d0-d1), at this time point we expect 
endothelial cells to express flk1 (Liao et al., 1997). Another 
batch was treated with 4-OHT only from late 4 dpf to late 5 
dpf (d4-d5) of embryonic development. 30-60hpf is the 
expected time of ETH as described by Kissa and Herbomel 
(2010), hence treating embryos from d4-d5 falls beyond this 
expected threshold (Kissa and Herbomel, 2010). We also kept 
a control batch of embryos that were treated with 100% 
ethanol (Table 4), the diluent used to make a 0.5µM solution 
of 4-OHT.  
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Table 4: Depicts the total number of embryos analysed 
from the cross between SN51♀4 to SN26 wt and 
treating the embryos at different time-points with 4-
OHT, which were then analysed for GFP and dsRed 









Embryos treated with 
+4-OHT 
       from d4-d5 
n=47 























24 11 10 21 26 0 20 25 1 
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On 5 dpf the embryos were analysed for dsRed expression and 
it was observed that the batch of embryos treated with 4-OHT 
from day0 to day1 showed dsRed expression in the 
endothelium and in the endocardium (Fig. 21 Aiii-v). However 
the number of dsRed positive cells in the CHT, intersomitic 
vessels and in the heart seems lesser in number when 
compared to the progeny of the same fish SN51♀4 (Fig. 21 Bii 
and Biii). This could suggest that recombination does not occur 
in all cells at the same time.  
Referring to Table 4 the 10 GFP+ and dsRed+ embryos were 
taken up to the nursery and are being grown under the stock 
number SN84. The kidneys of these fish will be analysed for 
dsRed positive cells once these fish are adults.  
 
Embryos that were treated with 4-OHT from late 4 dpf to late 
5 dpf could only be analysed for GFP expression and were 
sorted by dividing GFP positive and GFP negative embryos. 
There were no dsRed expressing embryos (Table 4) seen as on 
5 dpf when the embryos were analysed. 26 embryos only 
expressing GFP (Table 4) were taken up to the aquarium 
nursery and are growing up under the stock number SN88. 
Since we could not distinguish at this stage which of the GFP 
positive embryos may have done the recombination, we took 
all 26 embryos to the aquarium nursery. As mentioned earlier 
dsRed expression is only seen on 4 dpf to in embryos treated 
with 4-OHT from 10 hpf (tailbud stage). Hence, in embryos 
treated with 4-OHT from late 4 dpf to late 5 dpf we could 
expect to see dsRed positive cells on day9 to 10 dpf (if any 




The negative control batch of embryos was treated with 5µl of 
100% ethanol. Out of 46 embryos that were treated with 
100% ethanol 25 were GFP positive only (Table 4). 
Unfortunately in this negative control batch of embryos there 
was a single embryo that expressed dsRed in a one cell in the 
CHT (Table 4; data not shown). This just goes to show that no 
system is fool proof and perfect. However, we do not know 
whether this could have been due to a manual error while 
transferring embryos from one plate to another. In which case 
an embryo that might have been exposed to 4-OHT for a little 
while and might have remained in the pipette while 
transferring embryos into a fresh dish.  
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Fig. 23: qmc106 embryos treated with 4-OHT from late 
day0 (10hpf) to late day1 (d0-d1) 
All images were taken on 5 dpf.   
Ai-Aiii) shows the qmc106 taken along with a wt embryo from 
the same batch of treated embryos, as a negative control. 
Ai) Bright field image of a qmc106 embryo taken with a wild 
type (wt) embryo 
Aii) the same image as seen in the green channel to view GFP 
expression, as seen qmc106 is the GFP positive while the other 
embryo is a GFP negative wt embryo. 
Aiii-Av) the embryos as viewed in the red channel for dsRed 
expression.  
Aiii) The qmc106 shows dsRed expression in the thymus 
(white arrow), in the heart (green arrowhead) and dsRed 
positive cells in the CHT (yellow arrow), whereas the wt 
embryo displays no dsRed expression.  
Aiv) Gives a closer view of the trunk area of the qmc106 
embryo, which displays weak dsRed expression in intersomitic 
vessels (cyan arrows) and in the CHT (yellow arrow) 
Av) A magnified view of the head region of the qmc106 
embryo that showing dsRed expression in the thymus (white 









Our observations so far are only in the form of number of 
embryos that expressed dsRed, that too only in the batch that 
was treated with 4-OHT from d0-d1. Since our fish are still 
growing up in the aquarium nursery, we have not yet analysed 
their kidneys to trace our labelled cells. We could however 
logically analyse what we could expect to see in the kidneys of 
these fish once they are adults. 
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Fig. 24: Diagram that shows the expected results of 
lineage tracing experiments in which a green-to-red Cre 
reporter line is crossed to two lines that express a 
constitutively active and a conditional Cre in endothelial 
cells under the flk1 promoter. 
1) Shows recombination when the constitutively active flk1Cre 
is used. All cells that are Flk1 positive at any time point 
recombine and hence both endothelial as well as HSCs in the 
adult kidney would be dsRed positive. 
2) Shows no recombination should take place in the absence 
of 4-OHT and hence both endothelial and HSCs should be only 
GFP positive 
3) When 4-OHT is added from d0-d1 all blood and endothelial 
cells that express flk1 at this time point would be dsRed 
positive in the adult kidney, if the vDA gives rise to HSCs at 
d1-d3. 
4) In the case of delayed treatment with 4-OHT from d4-d5 
since the suggested time of ETH has already passed the vDA 
would be only GFP and not dsRed positive and nor would the 
blood cells that emerged from it, hence the blood cells in the 
adult kidney would be GFP positive. However the endothelial 
cells would be dsRed positive because they still express flk1. 
This would mean most blood cells arise de novo before 5 dpf. 
5) If however blood cells are dsRed positive in the adult kidney 
of embryos treated that were treated with 4-OHT from d4-d5, 
this would mean that blood cells continue to emerge from the 











4.4: Identification of dsRed- and GFP positive cells in 
kidney sections of transgenic adult zebrafish 
One of the seeding sites for haematopoietic stem cells during 
development of the zebrafish embryo is the kidney. The kidney 
is also the site for haematopoiesis in the adult fish (Ellett and 
Lieschke, 2010).  
After carrying out time point experiments on embryos from 
SN51♀4z we now have these fish growing up in the aquarium 
nursery. Only once these are adults can we analyse their 
kidneys for the presence of dsRed positive cells that we have 
labelled at different time-points using the flk1CreERT2 
recombination system.  
In the meantime, in order to trace the dsRed positive cells 
from the CHT of the early embryo that seed the kidney in the 
adult fish there were a number of steps that needed to be 
established. The following schematic diagram (Fig. 25) gives 
an over view on the steps that needed to be addressed in 
order to be able to view dsRed positive cells in the adult 
zebrafish kidney. 
Step 1 involved the dissection and isolation (Fig. 25) of an 
adult zebrafish kidney that was done according to a paper by 
Gerlach et al. (2011). The paper describes a step wise method 
of how a zebrafish can be dissected in order to isolate the 
kidney (Gerlach et al., 2011). Once dissected and all other 
internal organs are removed the kidney can be visualised 
under the dissecting microscope (Fig. 26A). The adult 
zebrafish kidney is a pinkish, translucent organ with a lot of 
blackish pigment cells and the dorsal aorta is associated to it 
(Gupta and Mullins, 2010). The kidney is made up of three 
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distinct anatomical regions, head, trunk/saddle and tail 
(Gerlach et al., 2011) (Fig. 26B). 
Step 2: The trunk of the fish containing only the kidney after 
dissection is placed in a container containing cold 4% PFA 
(fixation solution), and is left overnight (Gerlach et al., 2011). 
Fixing a tissue is done in order to preserve it and is hence a 
crucial part of tissue preparation. The next day the kidney is 
detached from connective tissue in the body cavity in order to 
isolate it. Technically, kidney isolation is followed by fixation. 
 
Fig. 25: Schematic representation of the steps involved 
in setting up procedures to view and analyse an adult 














            
 
Fig. 26: Adult zebrafish kidney isolation Gerlach et al. 
(2011) 
A) An adult zebrafish kidney as viewed under a dissecting 
scope before detachment from the dorsal body cavity. 
B) Schematic representation of the anatomical shape of the 






Step 3: After fixation and isolation of the kidney, the kidney 
was ready to be embedded and sectioned. Initially we thought 
that paraffin embedding and sectioning would work best, as it 
has been a method of choice for embryo sectioning. However 
when we did paraffin embedding and later sectioned, the 
sections did not seem to remain intact. Considering the kidney 
is a tissue that unlike an embryo is not tightly bound by 
structural proteins, could be a possible explanation for why the 
tissue seemed broken within the paraffin.  
We next turned to cryostat sectioning which included 
embedding the kidney into an optimal cutting temperature 
(OCT) compound. Embedding involved immersing the kidney 
into OCT, contained in a plastic mould. The plastic mould 
containing the OCT and kidney tissue is then placed over dry 
ice for instant freezing of the tissue. Once frozen the mould 
was left over night at -80¡C for further freezing. The next day 
the embedded tissue was ready to be sectioned on a cryostat. 
The embedding procedure for cryostat sectioning is quick and 
very simple and does not put the tissue through too many 
procedural steps that may damage the tissue.  
The kidneys were sectioned at 10micron sections and were 
applied on superfrost ++ slides. In order to stain the sections 
that were embedded in OCT, the OCT had to be first rinsed off 
the sections before carrying out further staining on them. We 
stained a section with hemotoxyllin and counter stained with 
eosin in order to get an over view of the morphology of the 
kidney (Fig.27). The histology of the adult zebrafish kidney 
has been described by Menke et al. (2011). Haematopoietic 





                              
Fig. 27: Morphology of a section of the adult zebrafish 
kidney.  A cryostat section of a wt adult zebrafish kidney that 
was stained with hemotoxyillin and counter stained with eosin. 
Black asterisks mark the tubules of the kidney and the green 
arrows point to the area of haematopoietic tissue in the 
kidney. 
Step 4: In order to be able to detect the recombined cells in 
the adult kidney from our lineage tracing experiments, it was 
important for us to standardise immunohistochemistry for GFP 
as well as for dsRed antibodies. 
Since this sort of immunohistochemistry experiments have not 
really been done on adult zebrafish kidneys there were a lot of 
trial and errors involved in establishing an effective method of 
detecting GFP and dsRed positive cells in this organ. 




Our aim is to find cells in the kidney and show that they are 
stem cells. In order to do that we first tried sectioning and 
immunohistochemistry on transgenic zebrafish lines that are 
known to express in the adult kidney.  
qmc551:gata1dsRed: To begin with we chose a double 
transgenic zebrafish line that had both a GFP as well as a 
dsRed reporter. This line was the qmc551:gata1 dsRed line. In 
this line the qmc551 has the gfi1:GFP and was used to see if 
GFP could be detected. The gata1 in the same line was used to 
establish a method of detecting a red fluorescent protein, 
namely dsRed.  
CD41:GFP was a second transgenic line we used in order to be 
able to detect GFP positive cells in the kidney. Ma et al (2011) 
described two populations of CD41-GFP+ cells in the kidney of 
CD41:GFP transgenic fish,  a GFP (hi) and a GFP (lo). They 
identified the GFP (lo) cells as cells with undifferentiated 
morphology, which suggested they are early progenitor cells, 
while the GFP (hi) cells were described as being mature 
thrombocytes (Ma et al., 2011). 
Flk1:GFP: Labels endothelial cells in the kidney and would give 
us an idea of what this would look like. 
Cre Reporter (GFP): sectioning and staining of the Cre reporter 
transgenic line would give us an idea of which cells would seed 
the kidney in the absence of recombination. This would also 
give us an idea of the activity of the ef1α promoter. Those 
cells that express GFP in the kidney have the ef1α promoter 
on in the adult kidney. These should be an entire population of 
GFP+ cells. 
Qmc101:Cre reporter (SN907): These fish have the qmc101 
(flk1CreXERT2) transgene and the Cre reporter. These fish 
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have the constitutively active Cre protein. The dsRed positive 
cells in the kidney of these fish should be a subset of the cells 
seen in the Cre reporter line. The common factor between the 
SN907 and the Cre reporter is the ef1α promoter. This line 
would also help us in setting up the immunohistochemistry for 
a red fluorescent protein, dsRed. 
SN919 Wild type (wt): It helped us set up cryostat sectioning.  
wt zebrafish adult kidney sections were used as negative 





4.5.1. Autofluorescence hampers unequivocal detection 
of GFP fluorescence in the adult kidney  
The qmc551 line is a gene trap line that labels with the GFP 
reporter the vDA when cells are hemogenic. From inverse PCR 
results it was seen that the reporter sits in the growth factor 
independence (gfi) 1.1 gene which is a homologue of the 
mouse Gfi1 (Thambyrajah, PhD 2012; Ucanok, personnel 
communication). Gfi1 positive cells would express GFP in 
myeloid progenitors in the adult kidney. This was done to see 
if GFP expression could be picked up in the adult kidney. 
Gata1 is an eryhthroid-specific transcriptional factor (Detrich 
et al., 1995) and would label erythroid progenitors which could 
be viewed as dsRed positive cells.  
Hence we made use of the double transgenic line to carry out 
immunohistochemistry on the kidney sections and to establish 
a method that would allow us to detect GFP and dsRed positive 
cells and to know what to expect in the kidneys of the fish we 
have labelled for lineage tracing using flk1CreERT2. 
We did this using fluorescent antibody staining, to detect GFP 
and dsRed (Fig. 28). A single green cell is observed; however 
there seems to be staining in the kidney tubules as well (Fig. 
28A). Since this was the first time we were doing this sort of 
experiment we were not really sure if what we were looking at 
was real staining or auto-fluorescence. Although it was more 
likely that the single green cell was real GFP staining as it lies 
in the haematopoietic tissue area of the kidney, hence chances 
of finding progenitors or HSCs is more likely in this region of 
the section. However the green colouration in the tubules was 
something that was more confusing. In order to differentiate 
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between auto-fluorescence and real GFP staining we stained a 




      
 
Fig. 28: Fluorescent immunohistochemistry staining 
done for detecting GFP+ and dsRed+ cells in the kidney 
section of a qmc551:gata1dsRed double transgenic 
adult zebrafish kidney. 
A) kidney section stained to detect GFP expression for gfi1 
cells. A single cell GFP positive cell (yellow arrow) is seen. 
Tubules (pink arrows) show green colouration. 
B) Section stained with dsRed antibody to detect gata1:dsRed 
positive cells. Many dsRed positive cells (cyan arrows) were 
observed. Tubules are not visible at this exposure time and 
were hence not annotated. 
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In the wild type kidney sections that were stained for GFP and 
dsRed there did not seem to be individual green or red cells 
but however the tubules did seem to be stained in both green 
and red (Fig. 29A and B). This would suggest that what we do 
see in the tubules of the transgenic lines was auto-
fluorescence. However the green fluorescence in the wild type 
kidney tubules seemed very bright and could thus suggest that 
there might be some kind of non-specific binding of the GFP 
antibody to some other protein in the tubules which was later 






Fig. 29: SN919 wt kidney section stained with GFP and 
dsRed antibody. 
A) Shows the section as seen in the green channel where 
tubules (pink arrows) are stained green. 





To differentiate between auto-fluorescence and non-specific 
binding of the GFP antibody to the kidney tubules, wt, 
CD41:GFP and flk1:GFP kidney sections were rinsed with 
buffer and were not stained with the antibody. In the wt 
section, although the green colour intensity seemed reduced 
there was still green staining (Fig. 30). This would suggest 
that what we see in these sections is auto-fluorescence.  
Kidney sections of the flk1:GFP and CD41:GFP were also 
looked at in the absence of staining with the GFP antibody 
(Fig. 31), there were other cells that were seen along with the 
green colouration in the tubules. Although the exposure time 
on the camera setting had to be reduced to image both of 
these sections due to the high intensity of the green 
colouration seen in the individual cells seen in the CD41:GFP 
sections (Fig. 31B) and elongated cells in flk1:GFP sections 
(Fig. 31A yellow arrowheads), tubules could still be seen in 
these sections. The morphology of the cells seen in the 
flk1:GFP kidney section fits with that of endothelial cells  and 
the individual cells seen in the CD41:GFP kidney section could 
suggest they are actually CD41 expressing cells. However we 
could not rule out auto-fluorescence that was seen in wt 
kidney sections (negative controls) and had to be absolutely 




              
 
Fig. 30: SN919 wt kidney section rinsed with buffer and 
not stained. 
Auto-fluorescence is seen in tubules (pink arrows) in a wild 
type (wt) kidney section in the absence of the GFP antibody. 
 
Fig. 31: flk1:GFP and CD41:GFP kidney sections rinsed 
with buffer and not stained, revealed other cells as well. 
A) A flk1:GFP kidney section Bright elongated cells lining 
tubules (yellow arrowheads) and tubules (pink arrows) 
B) Bright single cells (white arrows) and tubules (pink arrows). 




4.5.2. Using a streptavidin Alexa fluor 488 conjugate in 
combination with a primary biotinylated antibody reveal 
GFP positive cells in the kidney, but also gives non-
specific staining of extracellular matrix components 
Streptavidin has its drawbacks and is notorious for non-specfic 
binding. Leaving all other conditions of the 
immunohistochemistry protocol constant, and by either adding 
only primary or only secondary GFP antibody to CD41:GFP 
sections (Fig. 32) we confirmed that non-specific binding was 
in fact a problem.  
 
Fig. 32: Non-specific binding of secondary antibody 
streptavidin tested on CD41:GFP kidney sections 
A) Addition of only primary antibody and not secondary 
antibody give weaker green colouration in the tubules (pink 
arrow) 
B) Addition of only secondary antibody; no primary antibody 
added gives brighter green colouration in tubules (pink 
arrows) 
Both images were taken using identical camera settings. 
Hence with the problem of auto-fluorescence and non-specific 
binding of the streptavidin we decided to use DAB staining to 
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get a better overview on what kind of cells were labelled in our 
transgenic lines. 
4.5.3. A combination of a biotinylated primary antibody 
with the VectastainABC detection system allows 
unambiguous detection of GFP-positive cells in the adult 
kidney 
After a lot of trials, errors and modifications of available DAB 
methods we finally settled with a satisfying modified DAB 
staining protocol to detect GFP cells in adult zebrafish kidney 
sections. The only problem with using DAB was interference of 
endogenous peroxidase activity that gave a lot of brown 
colouration especially in tubules (Data not shown).  This 
however was abrogated using a 3% hydrogen peroxide (H2O2) 
in methanol. All GFP expressing transgenic kidney sections 
were stained using DAB staining and at the same time a wt 
kidney section was also stained as a negative control (Fig. 33).  
The SN919 wt kidney section showed negligible brown 
colouration (Fig. 33Ai), which is what we expected. We had 
managed to eliminate almost all of the endogenous peroxidase 
activity. 
The flk1:GFP kidney section showed brown staining in 
elongated cells that fit the description of endothelial cells, 
which are flk1 positive (Fig. 33Aii) and thus these cells are 
GFP positive cells. The number of cells with this morphology 
was extremely high. These cells were seen lining the tubules in 
the kidney. Endothelial cells line blood vessels and blood 
vessels are associated with all organs. Although we tried to get 
rid of endogenous peroxidase activity the flk1:GFP sections 
invariably had a slight brown colouration in some tubules (Fig. 
33Aii). Because of the high number of flk1 positive cells, the 
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time required for staining with DAB was lesser when compared 
to the other transgenic lines. However the time for staining 
might need to be reduced further.   
CD41:GFP cells are seen as single round cells spread all over 
the tissue section (Fig. 33Aiii). However as described by Ma et 
al we could not, atleast from our sections differentiate 
between the GFP (hi) and GFP (lo) low expressing cells. We 
could only see the whole population of CD41 cells. 
In the Cre reporter kidney sections there seemed to be more 
than one type of cell expressing GFP (Fig. 33Aiv) some round 
cells and some elongated cells were also observed in this 
transgenic kidney section. There also seemed to be a lot of 
brown patchy staining all over the tissue section. Since the wt 
kidney section did not show any such patchy staining pattern 
it could not be ignored completely. 
Finally the qmc551 section was stained to detect the gfi1.1 
expressing cells in the kidney, which seem to be few in 
number (Fig. 33Bii). These cells could be myeloid progenitors 
in the kidney. This kidney section was stained on a different 
day from the other above described lines. A different wt 
kidney section was also stained along with it to have a 




Fig. 33: GFP staining done using DAB on transgenic 
zebrafish lines 
Sections (Ai-iv) were stained together on the same day 
Ai) SN919 wt kidney section shows tubules (t) brown staining 
in this kidney section is negligible. The adult zebrafish kidney 
is associated with black pigment cells (yellow arrow). Some 
blood cells (black arrow) can also be seen in this section.  
Aii) flk1:GFP kidney section displays a large number of GFP 
positive elongated cells (blue arrowheads) lining tubules (t). 
Some blood cells (black arrow) probably erythrocytes are also 
seen. 
Aii) In the CD41:GFP kidney section a large population of GFP 
positive cells are scattered as single cells (green arrowheads) 
all over the tissue section. The tubules (t) seem to have 
negligible brown colouration just as in the wt kidney section. 
There seem to be a cluster of unstained blood cells (black 
arrow) present in the section, which could be erythrocytes.  
Aiv) The Cre reporter kidney section shows 3 type of stained 
cells, round single cells (orange arrowheads), elongated cells 
(pink arrow head) and patchy staining (green arrowheads). 
Pigment cells (yellow arrow) are also seen in this particular 
section and some erythrocytes (black arrow). 
Sections (Bi and Bii) were stained on the same day. 
Bi) wt kidney section shows negligible colouration in the 




Bii) in the qmc551 a very few number of cells are GFP positive 













4.6. Analysis of the progeny of the double transgenic of 
the qmc101;Cre reporter fish reveals that the flk1 
promoter is active in the germline 
Once we had detected GFP positive cells in transgenic lines 
that had the green fluorescent reporter, we now had to 
standardise a method of detecting dsRed positive cells in the 
adult zebrafish kidney. Finally it is dsRed positive cells that 
need to be detected in the kidneys of the fish from our lineage 
tracing experiment. We thus needed to look at transgenic 
zebrafish lines that would express dsRed in the kidney. We 
already had the qmc551:gata1 dsRed double transgenic line. 
The gata1: dsRed would be used to standardise a DAB 
immunohistochemistry staining to detect dsRed.  
We needed one more dsRed transgenic line in order to 
standardise our immunohistochemistry. We chose the SN907 
that carried the qmc101:Cre reporter. These fish carried the 
constitutively active flk1CreXERT2 (qmc101) along with the 
Cre reporter. However since we were not very sure of which 
fish among these were transgenic, we decided to cross them 
to wt fish to identify a transgenic and only once characterised, 
use it to isolate the kidney. 
On crossing the SN907 to a wt fish we were surprised to see 
that progeny of the cross gave no GFP expression in any of the 
embryos, but only expressed dsRed ubiquitously (Fig. 34). A 
male and a female SN907 fish were crossed to wt fish of the 
opposite sex.  
The progeny of the female expressed robust ubiquitous dsRed 
expression even at around the 2 somite stage (10.7 hpf) 
(earliest embryos were checked) which could indicate maternal 
mRNA contribution. Besides showing robust expression (Fig. 
  
108 
34C) of dsRed all (100%) of the embryos were red and no GFP 
expression (Fig.32B) was observed. This suggests that the 
SN907 female parent fish carried more than a single copy of 
the transgene.  
The progeny from the male SN907 fish also expressed only 
dsRed ubiquitously (Fig. 34F) and no GFP expression (Fig. 
34E) was observed. 50% of the embryos expressed dsRed 
suggesting that the male SN907 carried only a single copy of 
the flk1CreERT2:Cre reporter transgene. 
Overall this experiment unexpectedly showed for the first 
time, that the flk1 promoter is active even in the germline. 
Recombination of the loxP sites has taken place at some point 
in the germline of the parent fish, hence giving ubiquitous 
expression of the red reporter (dsRed) in the progeny. 
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Fig. 34: Flk1 is active in the germline of flk1Cre 
(qmc101):Cre reporter (SN907) fish  
A-C) Progeny of the SN907 female fish. (A) Embryo as seen in 
bright field (BF), (B) as seen in the green channel, the embryo 
is GFP negative, slight green colour seen is due to bleed 
through of robust dsRed expression. (C) same embryo as seen 
under the TRITC filter for dsRed expression, displays robust 
dsRed expression throughout the embryo.  
D-F) Progeny of the SN907 male fish (D) Embryos as seen in 
bright field (BF) (B) as seen in the green channel, both 
embryos are GFP negative, sl. (C) same embryos as seen 
under the TRITC filter for dsRed expression, ubiquitous dsRed 
expression seen in one; the other embryo was a sibling that 

















4.7. Immunohistochemistry allows detection of dsRed 
positive cells in the kidney of adult flk1Cre;Cre-reporter 
double transgenic zebrafish 
In order to be able to detect kidney cells in the flk1Cre;Cre-
reporter fish that had undergone loxP recombination earlier 
during development a method to detect dsRed-positive cells 
had to be established. For this purpose, a combination of a 
rabbit primary dsRed antibody with a horseradish peroxidase-
conjugated anti rabbit secondary antibody was tested on 
gata1-dsRed transgenic fish. In this line, dsRed is expressed in 
primitive and definitive red blood cells (Ellett and Lieschke, 
2010). Using DAB as a substrate, weakly dsRed-positive cells 
were detected scattered throughout the kidney section of this 
line (Fig. 35B), but were not found in kidney sections of wt 
controls (Fig. 35A 
 
Fig. 35: dsRed-positive cells were detected in the kidney 
of gata1:dsRed transgenic fish by immuno-
histochemistry 
A) A wildtype kidney section reveals the presence of tubules 
(black asterisks) and melanocytes (yellow arrow), but contains 
no DAB stained cells.  
B) dsRed-positive, DAB-stained cells were detected in between 
the tubules (asterisk) of the kidney of qmc551:gata1-dsRed 
double transgenic fish.  
  
112 
Having established the dsRed detection method, dsRed 
expression was next examined in the flk1CreXERT2qmc101;Cre-
reporter fish. First, dsRed expression was looked at in the 
transparent 6 day-old embryo. At 6 dpf, double transgenic 
embryos showed dsRed expression in the endothelium and 
endocardium, as well as in the thymus and in the kidney (Fig. 
36). This is consistent with the idea that cells from the CHT 
seed the thymus and the kidney by this stage.  
 
Fig. 36: dsRed expression pattern in 6 dpf 
flk1Cre(qmc101);Cre-reporter double transgenic 
embryos. 
A) A qmc101;Cre-reporter double transgenic embryo 
expresses dsRed in cells in the CHT, in the thymus (yellow 
arrowhead) and in the kidney. Taken with a wt negative 
control that showed no dsRed expression. The red 
fluorescence observed in the eyes of the transgenic and wt 
embryos is due to autofluorescence. 
B) A close up view of the head region the transgenic embryo 
(in image A), where the dsRed expression is clearly seen in 




Next, assuming that the ef1α promoter was also active in adult 
blood cells, dsRed expression was analysed in the kidney of 
adult double transgenic fish.  
For this experiment, two negative controls were used: (a) a 
section of a wt kidney and (b) a kidney section of a Cre-
reporter single transgenic fish (Fig. 37A and B). In these, no 
dsRed-positive cells were expected. Our results confirmed our 
expectations. 
Two kidney sections isolated from an SN907 double transgenic 
fish were taken from two different anatomical regions of the 
kidney, namely the head kidney (Fig. 37Ci) and the saddle 
(Fig. 37Cii). In both sections, individual dsRed-positive cells in 
between the tubules were detected (Fig. 37Ci and Cii). This 
shows that at least some blood cells are derived from cells 
that have expressed Cre under the control of the flk1 promoter 
and have undergone recombination of the loxP sites.  
Where the strong background staining visible in the section of 
the kidney saddle of the double transgenic animal came from 
is not clear as it was neither observed in the head kidney 
section of the double transgenic fish nor in the sections of the 











Fig. 37: dsRed expression in the kidney of flk1Cre:Cre 
reporter (SN907) double transgenic adult zebrafish. 
Sections of kidneys of wild type (A) and Cre reporter single 
transgenic (B) fish showed no staining with the dsRed 
antibody. 
Sections through the head (Ci) and saddle (Cii) portion of the 
kidney of the SN907 (flk1CreXERT2;Cre reporter) double 
transgenic fish revealed the presence individual dsRed positive 
cells (blue arrowheads) between the tubules (t). Black 
pigmentation reveals the presence of melanocytes (black 
arrows) associated with the kidney. Strong background was 







Chapter 5: Discussion 
5.1. dsRed expression level and pattern differences 
seen in the progeny of SN9 fish 
dsRed expression level differences were observed in the 
progeny of each of the 3 fish that were identified (SN9 ♂5, ♂6 
and ♂8). There could be a number of possible explanations for 
this difference. This could be due to the differences in copy 
number of the flk1CreERT2 transgene present in the 
chromosome. Higher the copy number, greater is the dsRed 
expression. Positional effects could also play a role in 
expression pattern differences, like in the qmc107 line that 
showed normal as well as ectopic dsRed expression. This 
would mean that the gene could have jumped into the vicinity 
of a regulatory element during integration into the genome.  
5.2. The SN51♀4z (flk1CreERT2) is a tight, non-leaky 
system  
We have seen that the flk1Cre in our qmc101 line labels more 
cells than our inducible flk1CreERT2, however looking at the 
progeny of the SN907 (flk1Cre;Cre reporter) (Fig. 34) we can 
be more confident of the inducible system in the SN51♀4z fish 
which is completely dependent on 4-OHT to carry out 
recombination. Even if the flk1 promoter is active in the 
germline of the SN51 fish never showed dsRed positive 
embryos as was seen in the progeny of the SN907 (Fig. 34). 
This indicates that no recombination takes place in the 
SN51♀4z fish in the absence of 4-OHT even in the germline. 





5.3. Immunohistochemistry is the method of choice to 
detect GFP positive cells in the adult zebrafish kidney 
Fluorescent immunohistochemistry on kidney sections has the 
risk of auto fluorescence and hence making it difficult to 
distinguish between GFP positive cells and false positives. 
Although the staining with the dsRed antibody was still better, 
sections looked messy due to too the auto-fluoresce.    
Dab staining is a better method of choice because most of the 
background cause by endogenous peroxidase activity was 
abrogated with H2O2 treatment. Hence making the sections 
look much neater making it easier to visualise dsRed or GFP 
positive cells.  
5.4. Is the ef1α promoter active even in the adult fish 
kidney? 
The ef1α has been seen to be most active in proliferating cells 
(Thummel et al., 2006) and hence its activity in the adult 
zebrafish kidney may be affected. From the SN907 
(flk1Cre:Cre-reporter) kidney sections (Fig. 37) that were 
stained to be able to visualise dsRed positive cells a very small 
number of cells seemed to be labelled. If there are HSCs that 
are quiescent and non-proliferative present in the kidney, then 
we might not be able to stain and hence visualise them if the 
ef1α promoter is not active in these cells. However these are 
sections of the kidney and not the entire kidney, so what we 
see are a very small percentage of the total cells actually 
present in the kidney.  
5.5. Future experiments 
As mentioned above visualising stained cells in kidney sections 
of the flk1CreERT2;Cre reporter or the flk1Cre;Cre-reporter 
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(SN907) is not enough to give us an idea of the kind of cells 
we are labelling, although they are assumed to be HSCs and 
endothelial cells. In order to do this we would like to flush cells 
out of the adult kidney and carry out a fluorescence-activated 
cell sorting (FACS) on the sorted dsRed-positive cells. Once we 
have these cells, we would like to spin them down on a 
cytospin and visualise the cells. This would help us identify, 
morphologically, under a microscope the type of cell. This 
would be done first on the SN907 adult kidney before looking 
at our fish from the lineage tracing experiments. 
If after further investigation we find that the ef1α promoter is 
causing us a problem we could try making new constructs 
using may be a tissue specific promoter, like the β-actin 




Chapter 6. Introduction to the the phosphotidylinositol 
3-kinase/protein kinase B signal transduction pathway  
6.1. The phosphotidylinositol 3-kinase/protein kinase B 
signal transduction pathway 
Here we are interested in studying the effects of the activating 
or blocking the phosphoinositide-3-kinase (PI3K) pathway 
specifically in the endothelium.  
Phosphotidylinositol/phosphoinositide-3-kinase (PI3K)/ protein 
kinase B (PKB/AKT) signalling pathway is known to be an 
important mediator of cytokine signalling implicated in 
regulation of haematopoiesis. PI3K are lipid kinases that 
phosphorylate the 3Õ hydroxyl group of phosphatidylinositol, 
for example: e.g: the membrane-anchored and most 
important substrate for class I PI3Ks is phosphatidyl inositol-
4,5-bisphosphate which gets phosphorylated to phosphatidyl 
inositol-3,4,5-triphosphate. The reaction catalysed by PI3K can 
be reversed by PTEN and SHIP2. 
3 distinct subclasses of phosphotidylinositol have been 
identified, however class I isoforms may be playing a role in 
haematopoiesis. ClassIA are heterodimers of a regulatory 
subunit p50α, p55α, p55γ, p85α and p85β and a catalytic 
subunit as p110α or p110β. Most PI3K are inactive in a cell 
and only small fractions get activated upon growth factor 
stimulation. 
PI3K is activated by a number of different membrane proteins 
that are receptors for various ligands, either directly like in 
platelet-derived growth factor receptor (PDGFR) or indirectly 
via ras as in case of epidermal growth-factor receptor (EGFR) 




AKT1 also known as protein kinase B (PKB) are a 57kDa 
serine/threonine kinase and has a number of different targets. 
In the presence of PIP3 AKT is moved to the membrane. At 
the membrane PIP3 binds to the pleckstrin homology (PH) 
domain of AKT. At the membrane AKT gets phosphorylated 
and thus activated at the T308 position on the threonine 
residue and at the S473 position on the serine residue by 
mTOR. AKT1 has a number of different targets and is hence 
involved in a number of cellular and metabolic functions. It 
plays a role in cell survival and inhibition of apoptosis (Jiang 
and Liu, 2009). 
6.2. Role of the phosphotidylinositol 3-kinase/protein 
kinase B signal transduction pathway in blood vessel 
formation! 
Although functionally distinct, arteries and veins arise from a 
common progenitor, the angioblast. The angioblast gives rise 
to both a functionally competent complex network of arteries 
and veins, that together comprise the vasculature. 
Hey2 is a transcriptional repressor in zebrafish (Hong et al., 
2006). The gridlock mutation is a mutation in Hey2, which 
encodes a hairy/enhancer-of-split related basic helix-loop-helix 
protein. Hey2 has been seen to play a vital role in the 
specification of arteries; and the gridlock mutation results in 
an insufficient number of arterial cells which in turn either 
causes a defect or loss of the aorta (Zhong et al., 2001). 
In an attempt to identify factors that are involved in arterial 
and venous fate decision Hong et al. (2006) treated gridlock 
mutants with a battery of chemical compounds like GS4012 
which was found to supress vascular defects in gridlock/hey2 
mutants by increasing vegf signalling. They saw that blood 
  
120 
circulation to the tail was restored via normal restored 
connection to the bilateral DA and the single medial DA. They 
also saw that GS4012 increased vegfA (vascular endothelial 
growth factor A) expression in gridlock embryos.  
Hey2 has been shown to be expressed downstream of vegf 
(Rowlinson and Gering, 2010). Hong et al then treated 
gridlock mutants with another compound GS4898 and this was 
also able to rescue gridlock mutants. This compound is a 
flavone compound like the PI3K inhibitor LY294002, 
suggesting that GS4898 must be targeting a kinase. The 
LY294002 compound was also seen to rescue gridlock 
phenotype. Hong et alÕs study suggested that AKT acts 
downstream of the PI3K pathway. 
In 2009 Herbert et al used flk1:GFP transgenics to track GFP 
positive angioblast cells during vascular development in the 
zebrafish embryo. They found that some of the angioblasts 
were seen to form sprouts from the dorsal aorta and 
connected to neighbouring cells to form the caudal vein. This 
suggested that arteries and veins share a common progenitor. 
They then used the PI3K inhibitor on the flk1:GFP transgenics 
and found that even though there was a vein, it did not 
express flk1:GFP, they observed that there were many cells 
retained in the DA. 
Thus the data from both the studies of Hong et al (2006) and 
Herbert et al (2009) suggests that PI3K/AKT plays a role in 
the specification of arteries and veins. 
6.3. Phosphotidylinositol 3-kinase pathway plays a role 




The rescue experiments done by Hong et al. (2006) led us to 
carry out LY294002 treatment on zebrafish embryos to study 
its effects on arterial/venous and blood cell formation. A 30µM 
solution of LY294002 (in DMSO) was used to treat embryos. 
This study showed that venous markers msr showed reduction 
while arterial markers seemed unaffected. Flk1 was not 
expressed however fli1 was relatively unaffected. Moreover 
there was a massive reduction in runx1, which would suggest 
that HSC formation is affected by blocking PI3K. 
Studying the effect of the PI3K inhibitor on the whole embryo 
gave a reduction in venous markers and in runx1, it would 
now be interesting to study the role of blocking or activating 
PI3K/AKT signal transduction pathway in the endothelium 
using a transgenic approach. 
Previously in the lab 2 constructs were cloned into a bluescript 
vector. The construct were; ef1α-loxP-Cerulean-terminator-
loxP-HA-AKT1-K179M which is a dominant negative AKT or 
kinase dead AKT (KDAKT). The second construct was the 
constitutively active AKT myristoylated (myrAKT) ef1α-loxP-
Cerulean-terminator-loxP-myrAKT. These constructs were 
injected into one-cell stage wt embryos (Fig. 38C). Both the 
transgenes contained a blue fluorescent reporter protein, 
cerulean which is floxed (Fig. 38A and B) and only in the event 
of recombination should there be gain or loss of function of 
PI3K/AKT signalling.           
After injection the embryos were checked for transient 
cerulean expression. Embryos that expressed cerulean were 
taken up to the aquarium nursery to be grown. 
Embryos that were injected with the transgene (ef1α-loxP-
Cerulean-terminator-loxP-HA-AKT1-K179M) transgene were 
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given the stock number SN44 and embryos that were injected 
with the transgene (ef1α-loxP-cerulean-terminator-loxP-
myrAKT) were given the stock number SN47. These fish were 







Fig. 38: Generation of 2 new transgenic founders 
A-B) The two constructs prepared previously in the lab.  
A) is the myrAKT construct 
B) is the KDAKT construct that were injected into wt embryos 




Chapter 7. Results 
Previous work carried out by Imran Khan and Christina Rhodes 
(Khan, MRes 2010, Rhodes, MRes 2010) in the lab included 
the treatment of wt embryos with LY294002 compound that is 
a PI3K inhibitor. 
This treatment was done on the whole embryo and not 
specifically on the endothelium. Further to their studies we 
were interested in studying the effect of activating or blocking 
the PI3K pathway specifically in the endothelium using a 
transgenic approach.  
7.1. Identification of KDAKT and myrAKT carriers 
amongst the SN44 and SN47 F0 fish 
In order to identify transgenic founders amongst the SN44 
(KDAKT) fish and the SN47 (myrAKT) fish, the SN44 and SN47 
were crossed with SN26 wt fish. Their progeny was examined 
for cerulean expression at 1 dpf. Because the integration of 
the transgene occurs after the first embryonic cleavages, the 
tissues of the founders are mosaic with respect to the 
transgene. One would therefore assume that as little as a few 
per cent of the gametes could be transgenic. Thus, we were 
required to get at least 100 embryos from each cross to find a 
transgenic embryo. 
Out of 16 crosses that were set up of the SN47 myrAKT fish 
only 2 fish gave embryos that displayed cerulean expression 
(see Table 5). These were ♂10z and ♀13L. 
It was observed that the single embryo that expressed 
cerulean among the progeny of the ♂10z SN47 myrAKT fish 
was an abnormal embryo (Fig. 39A). This had a heartbeat, 
however had no blood circulation and hence did not survive. 
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Cerulean expression however seemed robust (Fig. 39A). 
Abnormalities in the embryo and a high cerulean expression 
level could suggest that a high number of copies of the 
myrAKT transgene may have integrated into the genome of 
this embryo. This could have caused over expression of AKT, 
which caused the abnormalities in the embryo. Another 
explanation for this could be that there might have been some 
read through which causes the over expression of the AKT. 
Cerulean expression seems to be higher in the head, neck and 
tail regions of the embryo (Fig. 39A).  However, because this 
was only a single embryo from a single cross no more could be 
said regarding this. Sibling embryos analysed were all 
cerulean-negative and showed no abnormalities or defects as 
were seen in the single cerulean-positve embryo. SN47 was 
the founder of a new qmc line, qmc161. 
Another fish was identified as a potential founder of the 
myrAKT transgene and this was the SN47♀13L. 9 out of 39 
(table 5) embryos from this cross were cerulean positive (Fig. 
39B). 8 of these were normal and were taken up to the 
nursery to be grown under a new line number qmc162. The 
fact that this line did not show any significant abnormalities 
like in the qmc161 embryo could suggest that the terminator 
in the construct is sufficient to block most if not all expression 







Table 5: Depicts the number of embryos analysed and 
the percentage of the germline that is transgenic in 



















♂10z 265 1  0.38% qmc161 




Fig. 39: qmc161 and qmc162 were identified by 
cerulean expression 
A) The qmc161 was the single cerulean positive, abnormal 
embryo that expressed cerulean more robustly in parts of the 
head neck and tail regions (white arrows) as observed at 
around 30-32hpf. 
B) The qmc162 were identified by ubiquitous cerulean 
expression on 2 dpf. Cerulean expression in qmc162 was 
confirmed by comparing cerulean positive embryos to a sibling 
cerulean negative embryo. 
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7.2. Identification of founders from SN44 KDAKT fish 
A total of 16 crosses were set up out of which 4 fish were 
identified as being potential carriers of the KDAKT transgene. 
The founders were identified by the expression of cerulean 
among the progeny. Cerulean expression was confirmed by 
comparing the cerulean positive embryos to a cerulean 
negative control taken from the same batch (Fig. 40). 
The lines generated were qmc171, qmc172, qmc173 and 
qmc174. The number of embryos and the percentage of the 
germline that was transgenic are displayed in Table 6. 
Cerulean expression in the embryos from all the lines at 
around 25-28hpf was very convincing (data not shown) and 
hence the cerulean positive embryos were separated from 
their cerulean negative siblings. However, on 4 dpf cerulean 
expression seemed to have diminished in qmc171 and qmc172 
(Fig. 40A and B), as compared to qmc 173 and qmc 174 (Fig. 
40C and D), which made it extremely difficult to distinguish 
between a cerulean positive embryo and the negative control 
(Fig. 40A and B). Hence once the embryos from qmc171 and 
qmc172 are adults further investigation would be required in 
order to confirm whether they are transgenic or not.  All 
cerulean positive embryos were grown up. 
Expression level differences could be due to the number of 
copies of the transgene in the germline of the parent fish. As 
mentioned earlier injection of the transgene at the one cell 
stage results in mosaicism due to which the percentage of the 
germline which is transgenic is relatively low in these fish. 
Furthermore positional effects could also be a possible 




Table 6: Shows the results obtained from crossing the 
SN47 KDAKT to wt fish in terms of numbers and the 

























♀1z 71 5 w 7.04% qmc171 
♂2z 32 2 w 0.63% qmc172 
♂4z 234 25 + 10.68% qmc173 
















Fig. 40: 4 qmc lines generated by crossing the SN44 
KDAKT fish to wild type fish 
Cerulean expression as seen on 4 dpf 
A-B) qmc171 and 172 show very weak cerulean expression 
and can barely be distinguished from the negative control 
(cerulean- embryo) 
C-D) qmc 173 and 174 show convincing cerulean expression 






In summary we have identified and established new qmc lines, 
qmc161 and qmc162 for the myrAKT fish. However, qmc161 
was an abnormal embryo that had not survived, and the 
parent was recrossed later but did not yield embryos in the 
next cross. Qmc162 were 8 embryos that expressed cerulean 
and had no defects, hence we discontinued the qmc161 line 
and decided to work with the qmc 162 line.  
qmc171, 172, 173 and 174 were established by the KDAKT 
fish. Although cerulean expression levels were not convincing 
in qmc171 and 172 we grew them to analyse them in the next 
generation. 
For further reference and convenience the stock numbers of 
the qmc162 fish is SN69 and that of the qmc174 fish is SN81. 
However in order to carry out our further studies a single fish 
from each line would be sufficient. We could only decide which 
fish we wanted to work with and which lines we could 
discontinue by looking at the F2 fish. 
7.3. Analysis of the F1 generation of myrAKT and KDAKT 
fish 
Once we had established the myrAKT qmc 162 and the 
KDAKT1 qmc 171, 172, 173 and 174 lines and these fish that 
were the F1 generation were now adults and ready to breed, 
we decided to cross them to wild type fish and analyse the 
progeny (F2 generation). 
7.4. Analysis of F2 embryos from F1 qmc162 myrAKT 
fish 
To analyse the F1 fish we crossed them to wild types (wt). 
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Out of a total of 5 crosses that were set up 3 were successful, 
however, the progeny of only one fish expressed cerulean. 
This was the qmc162 ♀1L. The progeny of this female showed 
expression level differences, where 130 embryos were 
cerulean positive (hi) and 57 embryos were cerulean positive 
(lo) (Table 7) (Fig. 41B). Cerulean expression was not very 
convincing on 2 dpf as seen in (Fig. 41B). However cerulean 
expression was stronger in younger embryos in the same 
batch (Fig. 41C). Younger embryos may be present in the 
same batch if the fish would have laid at 2 or 3 different 
occasions while in the breeding tanks. Could the EF1α 
promoter be responsible for the decrease in cerulean levels as 
time progressed?  
The ratio of cerulean negative to the total number of cerulean 
positive [cerulean+ (hi) + cerulean+ (lo)] embryos, which is 
not a 50-50% split (Table 7), would indicate that the parent 
fish has more than one copy of the transgene.  
Currently, there are 25 high expressing and 25 low expressing 
cerulean positive embryos were taken up stairs to the nursery 
to be grown the stock number given to them was the same 
SN101, although kept in separate tanks. This is the F2 
generation of myrAKT fish. 
 Table 7: shows the number of embryos analysed for 
cerulean expression when myrAKT qmc162 ♀1L was 
crossed to wt fish 















Fig. 41: qmc162 F2 generation 
A) A bright filed image of three sibling embryos 
B) Shows cerulean+ (hi) and (lo) expressing embryos. 
Cerulean expression was not very convincing on 2 dpf. 
C) a younger embryo from the same batch expresses cerulean 
at a higher level than an older sibling. 





There seems to be leakiness of myrAKT observed in the male 
germline. Although this was only an observation and needs 
further investigation, the progeny of myrAKT males rarely 
expressed cerulean, even though the parent had expressed 
cerulean as an embryo. On rare occasions, when cerulean 
expression was observed, it would be in1 or 2 embryos that 
expressed cerulean at high levels but were abnormal embryos 
(data not shown), similar to the qmc161 embryo (Fig. 39A). 
This shows that the fish is still a carrier. Also, considering the 
fact that the parent had expressed cerulean, indicates that the 
parent must have the transgene. This makes us wonder 
whether the transgene has an adverse effect in the male 
germline when passed on? This needs further investigation.  
7.5. Analysis of F2 embryos from F1 KDAKT fish 
Although 4 qmc lines were established with the KDAKT fish, 
namely qmc171, 172, 173 and 174, we decided to maintain 
and work with only qmc174 line.  
Fish from qmc171, 172, 173 and 174 were crossed to check 
for cerulean expression; however no expression was seen in 
the progenies of qmc171 and qmc172 fish. Which was 
expected as the embryos did not express cerulean very 
convincingly before they were grown (Fig. 40A and B). 
Surprisingly although qmc173 gave decent expression of 
cerulean (Fig. 40C) its progeny did not express cerulean very 
convincingly (data not shown). As seen above (Fig. 40) the 
most convincing cerulean expression was seen in the qmc174 
(Fig. 40D) embryos and will hence be used to carry out further 
experiments.  




7.6. Analysis of F2 embryos from F1 qmc174 KDAKT fish 
A total of four crosses were set up with wt fish. Three of these 
were successful. The progeny of all of the fish were then 
analysed for cerulean expression on 1 dpf. Cerulean 
expression was observed in progeny from all of the 3 fish 
crossed, which confirmed the parents were all transgenic. For 
convenience, in Table 8 embryos are broadly divided as 
cerulean positive and cerulean negative. The numbers (Table 
8) suggest that ♀2z has more than one copy of the transgene, 
hence there isnÕt a 50-50% split between cerulean positive 
and cerulean negative embryos. The cerulean positive 
embryos were more in number. The female is more than 90% 
transgenic. ♂4z is 52.3% transgenic. ♂3z seems to have only 
one copy of the transgene where the ratio of cerulean positive 
embryos to cerulean negative embryos suggests it is almost 
50% transgenic. 
A variation in expression levels was observed among the 
progenies of all three fish (data shown only of ♂3z) Fig. 42B). 
This could be due to positional effects of the transgene.  
Table 8: shows the number of embryos analysed from 










♀2z 182 17 165 
♂3z 289 148 141 






Fig. 42: The progeny of SN81qmc174♂3z shows 
variations in cerulean expression among its progeny 
A) Bright field image of 4 embryos taken together. 
B) Three different levels of cerulean expression were observed 
among siblings. The expression level differences were 
compared to a wt embryo from the same batch. 
Since the embryos from SN81♂3z gave 50% cerulean positive 
and 50% cerulean negative embryos 50 of the cerulean 
positive embryos were taken to the aquarium nursery and 
were given the stock number SN112. These were the F2 





In summary we now had F2 generation fish from both the 
transgenic lines, namely the myrAKT and the KDAKT lines. 
These fish would be used to carry out further experiments. 
7.7. Recombination of the loxP sites in both the myrAKT 
and the KDAKT did not give a phenotype 
As we already know the 2 constructs for the KDAKT and the 
constitutively active myrAKT have loxP sites in them (Fig. 38A 
and B). Recombination of the loxP sites, using a constitutively 
active Cre protein (flk1Cre) should either block (in case of the 
KDAKT transgene) or activate (myrAKT) the PI3K pathway in 
the endothelium.  
Hence to see if this actually works the KDAKT was crossed to a 
qmc101 (flk1Cre). However we did not get any significant 
phenotype in the embryos obtained from this cross.  
Since there were no obvious phenotypes observed in the 
endothelium of the embryos for the cross between the KDAKT 
fish and the qmc101 (flk1Cre) line this could either indicate 
that there might be some subtle defects with respect to blood 
vessel formation or HSC specification, which cannot be 
visualised without a reporter. We thus decided to cross the 
myrAKT and the KDAKT fish to fli1:GFP in order to be able to 
see defects in the endothelium. Fli1 like flk1 is an endothelial 
marker. These fish are now growing up.  
In summary recombination using the constitutively active Cre 
protein did not show any significant phenotypic defect. This 




Chapter 8. Discussion 
We have identified founders of the myrAKT and KDAKT fish 
and have upto F2 generations fish growing. We would in the 
future use these to study the effect of blocking or activating 
the PI3K/AKT signal transduction pathway on the endothelium 
and HSC specification.  
8.1. Cerulean expression absent in progeny of male 
myrAKT fish 
As seen in the result section the progeny of male myrAKT fish 
most often failed to express cerulean. In case cerulean was 
expressed it was expressed at high levels in a mere 1 or 2 
embryos that were abnormal. If these fish were cerulean 
positive as embryos then what would be the reason of them 
not giving cerulean positive embryos? The fact that there were 
occasional cerulean expressing abnormal embryos would 
indicate that the transgene might be present. This would need 
to be investigated by carrying out a PCR on the cerulean 
negative progeny of the male fish to check for the presence of 
the transgene. Furthermore, abnormal embryos seen with high 
cerulean expression could indicate that there might be some 
read through of the myrAKT which causes these defects. 
Hence this could be addressed either by increasing the polyA 
tails or putting a stop cassette. 
8.2. The ef1α promoter could be replaced 
Previously in the lab constructs were made for the NICD and 
dominant negative rbpj to study the Notch pathway. The 
myrAKT and the KDAKT were made using the same constructs 
where NICD or the dominanant negative rbpj were replaced by 
the myrAKT or the KDAKT. Hence Mohammad who is working 
on the notch lines faced similar problems with cerulean 
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expression levels which in our constructs are driven by the 
ef1α promoter.  Mohammad is working towards replacing the 
ef1α promoter with the ubiquitin promoter, in order to get 
more robust cerulean expression. The fact that the cerulean 
expression diminishes in embryos as time progresses could be 
abrogated by using another promoter.  
8.3. Recombination using flk1Cre qmc101 line gave no 
phenotypic defect in KDAKT fish 
In order to get a loss or gain of function in the KDAKT or the 
myrAKT embryos we need to recombine the loxP sites in the 
transgene. As mentioned earlier this was done on the KDAKT 
fish that were crossed to the flk1Cre qmc101 line in order to 
get a loss of function. We however did not see any obvious 
phenotype. This made us wonder if it could be due to a 
mutation in base pairs of the KDAKT fragment. However we 
got both the myrAKT and KDAKT fragments sequenced and 
sequencing data revealed that both sequences are fine and 
have no mutations. Hence we could rule out that the myrAKT 
or KDAKT were not functioning properly. 
Mohammad also tried injecting Cre mRNA into the embryos to 
get recombination and still got no significant phenotype. 
Are there subtle defects that cannot be visualised due to the 
absence of a second reporter? How much of the KDAKT or 
myrAKT is required to be translated in order to give a 
significant phenotype of loss or gain of function?  
Subtle defects if any could be viewed by crossing the myrAKT 
or KDAKT fish to a fli1:GFP fish. This double transgenic fish 
can then be crossed to the flk1Cre in order to get 
recombination. Now that there is a fli1:GFP transgene in the 
background that labels the endothelium, we would be able to 
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view any loss or gain of function in blood vessel formation. In 
a similar way by crossing the myrAKT or KDAKT fish to the 
enhancer trap line qmc551 (gfi1:GFP) we could visualise the 
effect of blocking or activating PI3K/AKT on HSC specification.   
8.4. PI3K/AKT Cell autonomous or non-cell 
autonomous? 
Past studies done in the lab with the LY294002 compound that 
is a known PI3K/AKT inhibitor have shown significant reduction 
in venous and HSC transcriptional factor runx1. Is PI3K/AKT 
signalling a requirement of the cell itself or is it a requirement 
of the cell next door? This is a question that needs to be 
addressed in future experiments with the help of blocking or 
activating the PI3K/AKT signalling pathway using the lines 
established qmc174 and qmc162. 
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